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SUPPLEMENTARY NOTES 
Supplementary Note 1: Detailed consideration of theoretical diversity and InDel 
redundancy 
The theoretical diversity (i.e., the total number of possible variants) accessible via such 
modifications will depend both on the type of InDel that is introduced and on the target 
sequence (Supplementary Figure 5). For instance, as deletions can occur once at each 
position of the target DNA sequence, the maximal possible theoretical diversity of deletion 
libraries is identical to the number of nucleotides (Supplementary Figure S5A), e.g., ~1,000 
possible deletion variants for a ~1 kbp target sequence (e.g., wtPTE). By contrast, since 
TRIAD inserts degenerate nucleotide triplets (e.g., [NNN]1, 2 or 3 corresponding to 64 (=43), 
4,096 (=46) and 262,144 (=49) possible sequences, respectively), the number of possible 
insertion variants will depend both on the length of the target sequence and the size of the 
insertions. The maximal possible theoretical diversity for insertion libraries generated from 
wtPTE is 6.4104 (=64103), ~4.1106 (=642103), and ~2.6108 (=643103), corresponding to 
+3, +6 and +9 bp insertions, respectively (Supplementary Figure S5A). Because of potential 
InDel redundancy depending on the target sequence (i.e., two or more neighbouring InDels 
can result in the same DNA variant; Supplementary Figure S5B), the theoretical diversities 
accessible from a given DNA sequence are usually lower (see Supplementary Figure S5C in 
the specific case of wtPTE). Theoretical diversities at the protein level (i.e., the number of 
protein variants that have the intended InDel length) are further reduced due to codon 
degeneracy and occurrence of stop codons as a result of certain InDels (Supplementary 
Figure S5C). Practically, the size of our libraries was limited by transformation efficiency, 
achieving > 106 variants upon transformation into E. coli. Therefore, deletions as well as +3 
bp insertions were oversampled such that the library diversity was maintained between 
transformations, while the diversity of sampled transposition sites was maintained in larger +6 
bp and +9 bp insertion libraries, with only a fraction of theoretical library diversity generated 
from the outset. 
Supplementary Note 2: Library quality assessment by Sanger sequencing 
In addition to the deep next-generation sequencing described in the main text, the accuracy of 
the TRIAD approach (specifically the number of intended in-frame InDels, unwanted 
frameshifts and incidental mutations) was also assessed using Sanger sequencing to give the 
reader a picture how such an ‘everyday analysis’ of a handful of individual wtPTE InDel 
variants would fare. To this end around 20 colonies from each naïve InDel library of individual 
wtPTE variants were randomly picked (after the final transformation step into E. coli) and 121 
variants in total sequenced (Supplementary Tables S1-3). All the sequenced variants 
displayed only a single modification resulting from the initial transposon insertion and 90 
among them (74%; corresponding to 89 unique InDels) showed anticipated in-frame InDel 
mutations (86% of the deletion variants; 61% of the insertion variants; Supplementary Tables 
S1-2). Most in-frame InDels were observed only once and were distributed throughout the 
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wtPTE sequence (Supplementary Table S3). No frameshift was observed among sequenced 
variants from the -3 bp library, which is generated without shuttle cloning steps in contrast to 
the other libraries. Frameshifts were more frequent among variants from the +3, +6 and +9 bp 
insertion libraries (~40% of the sequenced variants). Higher frameshift frequency in insertion 
libraries may be due to exonuclease over-digestion by the Klenow fragment of DNA 
polymerase I, which removes 3’ overhangs left by AcuI digestion (Figure 2B). Note that no 
incidental additional base pair point mutations located elsewhere in the variants’ sequence 
(i.e., at positions different to that of the initial transposon insertion sites) and resulting from the 
TRIAD cloning process were detected. On the protein level, TRIAD may generate a 
secondary point substitution contiguous to the introduced InDel 1, depending on the point of 
insertion of TransDel or TransIns in the reading frame of the target sequence. This occurs 
when the InDel is not inserted at previous codon boundaries (statistically in two of three 
cases, although not all such events lead to amino acid substitution). As a result, 22% of the 
InDels observed in individual wtPTE variants exhibited such an adjacent substitution. 
We conclude that the accuracy of the TRIAD procedure can be assessed based on a 
small number of sequences (n = 121, giving 89 unique in-frame InDels), to provide a quality 
control step informing in TRIAD library synthesis that is a representative measure of the 
distribution of InDels over the target sequence and assess the coverage afforded by the initial 
transposition step prior to diversification via InDel mutagenesis (Table 1), in lieu of a deep 
next-generation sequencing approach. 
Supplementary Note 3: Effects of InDels vs. point substitutions on soluble enzyme 
expression 
InDels are more detrimental to the fitness of wtPTE by one order of magnitude in comparison 
to point substitutions (see main text; Figure 5C). Enzyme fitness is reflective of both enzyme 
activity (i.e., catalytic efficiency) and the concentration of soluble and functional enzyme which 
itself relate to protein stability 2. Thermodynamic stability (i.e., the difference in free energy 
between the native and unfolded state in vitro) is often used to describe the relationship 
between protein stability and soluble and functional expression in the cell (e.g., p53)3. 
However, in the case of wtPTE, the level of soluble and functional enzyme has previously 
been shown to correlate with kinetic stability (related to folding kinetics during expression in 
the cell) 4. Therefore, to further investigate the stability effect of InDels vs. point substitutions, 
changes in expression levels of several InDel (TRIAD libraries: -3 bp deletions and +3 bp 
insertions) and point substitution (TriNEx library) variants were examined and correlated with 
fitness (native phosphotriesterase activity against paraoxon, measured in cell lysates) 
(Supplementary Figure S11; Supplementary Tables S11-12; see also supplementary 
methods). Overall, this analysis confirmed that InDels are more deleterious to soluble 
expression and protein stability than substitutions. Indeed, 17 out 30 deletions and 11 out of 
27 insertions were found to be strongly destabilizing (> 2-fold decrease in soluble expression 
relative to wtPTE) while this was the case for only 6 out of 30 substitution variants 
(Supplementary Figure S11; Supplementary Tables S12). Likewise, the average impact on 
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soluble expression (mean solubility change) was up to 1.5-fold lower for InDels in comparison 
to substitutions (Supplementary Table S12). The stronger decrease in protein solubility 
observed in the case of InDels was also correlated to their more detrimental effect on fitness 
(enzyme activity) (Supplementary Figure S11; Supplementary Table S12). 
Interestingly, some InDels affecting core residues that are relatively distant from the 
enzyme’s catalytic centre were functionally deleterious (< 10-fold decrease in PTE activity) 
while retaining similar soluble expression levels (≤1.5-fold change) to the parent wtPTE 
(Supplementary Table S12). Indeed, while average distances to the catalytic metals for all 
solubility-neutral mutations were similar (16.4 ± 5.1, 17.3 ± 5 and 16.5 ± 5.6 ångströms for 
deletions, insertions and substitutions, respectively; Supplementary Table S12), non-
destabilizing but functionally deleterious insertions and deletions were on average more 
distant to the active site than substitutions (13.9 ± 4.8 and 16.8 ± 5 ångströms for deletions 
and insertions, respectively versus 9.9 ± 3.3 ångströms for substitutions; Supplementary 
Table S12). This observation illustrates how InDels may trigger active site changes with 
functional effects at a longer range than substitutions. 
 Supplementary Note 4: Focused InDel libraries generated by TRIAD 
TRIAD was additionally applied to focus the InDel mutagenesis on a specific targeted region 
within a protein by adding an in-frame seamless cloning step using a type IIS restriction 
enzyme such as SapI (strategy outlined in Supplementary Figure S17) 5. This approach 
requires the target region to be extracted from its original gene and cloned in its own target 
plasmid with flanking SapI recognition sequences. This allows transposon integration into the 
target region in isolation from the rest of the gene. In parallel, an adapter plasmid is 
constructed, comprising the original gene in which the target region is replaced by an adapter 
sequence. This adapter sequence is designed with flanking SapI recognition sequences in 
order to allow the subcloning of the target region containing the randomly inserted transposon 
back inside its original gene. This last step results in the generation of the transposon 
insertion library focused on the region of interest, upon which the cloning steps of TRIAD 
leading to the generation of InDel libraries (Figure 1) can be performed.  
To demonstrate this targeted approach of TRIAD, two deletion (-3 and -6 bp) and one 
insertion (+3 bp) libraries were generated in the sequence encoding wtPTE’s active site loop 
7 (L7), which has shown to be crucial for the specificity of wtPTE and homologous lactonases 
in previous rational InDel mutagenesis studies 6, 7. In vitro transposition reactions were 
performed on a vector containing the L7 - encoding DNA sequence (from Leu252 to Gln278; 
81 bp) flanked by SapI restriction sites (Supplementary Figure S13). After isolation by SapI 
digestion, the resulting L7 TransDel and TransIns insertion libraries were then subcloned into 
a plasmid containing a modified wtPTE gene with a SapI-adapter instead of L7. This 
additional cloning step enabled to recreate a full wtPTE gene with TransDel or TransIns 
randomly inserted - in theory - at all 81 positions within L7. After application of the further 
steps of TRIAD, libraries with insertions and deletions limited to L7 only were generated. 
Intermediate and final library transformation steps yielded diversities of >106 variants, 
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practically oversampling by >105-fold the theoretical diversity of the libraries (81 possible 
transposon insertion sites in L7). Sequence analysis of randomly chosen variants revealed 
the distribution of codons deleted in L7. Whilst there is good coverage of the target sequence 
(~70% of residues are deleted at least once), there is a bias of deletions toward certain 
residues, especially Leu262, Leu272 and the residues neighbouring them (Supplementary 
Table S15). These biases are likely caused by preferential transposon insertions at specific 
points along the DNA sequence encoding Loop 7.  
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SUPPLEMENTARY METHODS 
Supplementary Method S1. Design, construction and preparation of transposons 
and cloning cassettes 
DNA sequences corresponding to the TransDel transposon (Supplementary Figure S2A) and 
the Del2 cassette (previously dubbed Insertion Replacement Cassette in 8) were synthesized 
and cloned into pUC57 (Supplementary Figure S2D) at the EcoRV site (GenScript, NJ, USA). 
Cloning strategies involving double stranded oligonucleotide adapters (Supplementary Table 
S14) were used to generate pUC57-TransIns (Supplementary Figure S2A) from pUC57-
TransDel, and pUC57-Del3 (Supplementary Figure S2B), -Ins1, -Ins2 and -Ins3 
(Supplementary Figure S2C) from pUC57-Del2. For all adapter cloning experiments, each 
pair of custom phosphorylated oligonucleotides (100 μM in 50mM Tris-HCl pH 8.0, 100 mM 
NaCl, 1mM EDTA) were mixed to a final concentration of 50 μM and annealed in a PCR 
thermocycler ((1) 2 min at 95°C, (2) 10 min at 52°C and (3) hold at 4°C). The resulting 
adapters were then ligated to a final concentration of 125 nM into their target plasmid (50-100 
ng). The ligation products were then transformed into electrocompetent E. coli E. cloni® 10G 
cells. Plasmid pUC57-TransIns was generated by inserting the TransIns adapter in pUC57-
TransDel at EcoRI/SpeI sites. Plasmid pUC57-Del3 was obtained by inserting the Del3 
adapter in pUC57-Del2 at EcoRI/SpeI sites. Plasmids pUC57-Ins1, -Ins2 and -Ins3 
correspond to libraries of inserts of one, two and three nucleotide triplets, respectively. First, 
an intermediate plasmid, dubbed pUC57-Ins, was obtained by inserting the Ins adapter in 
pUC57-Del2 at EcoRI/SpeI sites. Adapters Ins1, Ins2 and Ins3 were then inserted in pUC57-
Ins at NcoI/HindIII sites to generate separate plasmid libraries corresponding to pUC57-Ins1, -
Ins2 and -Ins3, respectively. In this last step, each DNA library was extracted from around 107 
E. coli Ecloni® 10G transforming colonies. 
Supplementary Method S2. Design and assembly of pID vectors 
Two expression vectors, dubbed pID-T7 (expression under the control of T7 promoter) and 
pID-Tet (expression under the control of Tet promoter), were specifically designed for the 
generation of InDel libraries following the TRIAD approach. These vectors do not contain any 
MlyI, AcuI and NotI restriction sites in their sequence and were assembled from three different 
modules (for origin of replication, ampicillin resistance (AmpR) selection and 
expression/cloning) separated by three restriction sites, AflII, AatII and SpeI (Supplementary 
Figure S4). 
Origin of replication module. Two successive site-directed saturation mutagenesis 
experiments (using primer pairs Ori-MlyI and Ori-AcuI; Supplementary Table S14) were 
performed to remove recognition sites for MlyI and AcuI in the origin of replication (ori) of 
pUC19 used as starting template. Successful removal of the recognition sequences was 
confirmed by the absence of restriction digest product with the corresponding enzyme. The 
final ori variant (i.e., with no MlyI and AcuI) was then amplified with primers Ori-AflII and Ori-
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SpeI (Supplementary Table S14), yielding the origin of replication module (framed by AflII and 
SpeI) for the pID vectors. 
Ampicillin resistance selection and T7 expression modules. The sequences 
corresponding to the T7 expression (Supplementary Figure S4B) and AmpR cassettes 
(Supplementary Figure S4D) were synthesized by GenScript (NJ, USA). Position T8 of the T7 
promoter was mutated to C to remove the MlyI site present in the natural promoter 9. Silent 
mutations were introduced in the AmpR sequence to remove recognition sites for AcuI and 
FokI. 
Assembly of pID-T7. The DNA cassettes corresponding to the modified ori (AflII /SpeI), 
AmpR (AflII /AatII) and the T7 expression module (AatII/SpeI) were isolated by double 
digestion with their corresponding restriction enzymes and agarose gel purification. A ligation 
reaction with 50 ng of each DNA fragment was then performed using T4 DNA ligase 
(Fermentas) overnight at 18˚C. After purification, the ligation products were transformed into 
electrocompetent E. coli Ecloni® 10G cells subsequently plated on LB-agar supplemented 
with 100 µg/mL ampicillin. The pID-T7 constructs extracted from the resulting transforming 
colonies were confirmed by restriction digestion profile and sequencing. 
Generation and assembly of pID-Tet. TetR (encoding the Tet repressor) was amplified from 
pASK-IBA5plus (IBA Lifesciences) with primers TetR-F and TetR-B (Supplementary Table 
S14). AmpR was amplified from pID-T7 with primers mTEM1-F and mTEM1-B. The SpeI/AatII 
module for pID-Tet containing the AmpR-TetR operon was obtained by overlap PCR of these 
two products with primers mTEM1-F and TetR-B and subsequently inserted into pID-T7 at 
SpeI/AatII sites (replacing the AmpR cassette) to yield pID-T7-TetR. The Tet promoter 
sequence was amplified from pASK-IBA5plus with primers TetProm-F and TetProm-B and 
inserted into pID-T7-TetR at the AflII/NdeI sites (replacing the T7 promoter), yielding plasmid 
pID-Tet. 
Supplementary Method S3. wtPTE reference sequence 
>wtPTE 
ATGGCCAGATGATTAATTCCTAATTTTTGTTGACACTCTATCATTGATAGAGTTATTTTACC
ACTCCCTATCAGTGATAGAGAAAAGTGAAATGAATAGTTCGACAAAAATCTAGAAATAATT
TTGTTTAACTTTAAGAAGGAGATATACATATGGCTAGCTGGAGCCACCCGCAGTTCGAAA
AAGGCGCCGGATCCTCCATGGGCGATCGGATCAATACCGTGCGCGGTCCTATCACAAT
CTCCGAGGCGGGTTTCACACTAACCCACGAGCACATCTGCGGCAGCTCGGCAGGATTC
TTGCGTGCTTGGCCGGAGTTCTTCGGTAGCCGCAAAGCTCTAGCGGAAAAGGCTGTGA
GAGGATTGCGCCGCGCCAGAGCGGCTGGCGTGCGAACGATTGTCGATGTGTCGACTTT
CGATCTCGGTCGCGACGTTAGTTTATTGGCCGAGGTTTCGCGGGCTGCCGACGTTCATA
TCGTGGCGGCGACCGGCTTGTGGCTCGACCCGCCACTTTCGATGCGATTGAGGAGTGT
AGAGGAACTCACACAGTTCTTCCTGCGTGAGATTCAATATGGCATCGAAGACACCGGAA
TTAGGGCGGGCATTATCAAGGTCGCGACCACAGGCAAGGTGACCCCCTTTCAGGAGTTA
GTGTTAAGGGCAGCTGCCCGGGCCAGCTTGGCCACCGGTGTTCCGGTAACCACTCACA
CGGCAGCAAGTCAGCGCGGTGGTGAGCAACAAGCCGCCATTTTTGAATCCGAGGGCTT
GAGCCCCTCACGGGTTTGTATTGGCCACAGCGATGATACTGACGATTTGAGCTATCTCA
CCGCCCTCGCTGCGCGCGGATACCTCATCGGTCTAGACCATATTCCGCACAGTGCGATT
GGTCTAGAAGATAATGCGAGTGCATCAGCCCTCCTGGGTATTCGTTCGTGGCAAACACG
GGCTCTCTTGATCAAGGCGCTCATCGACCAAGGCTACATGAAACAAATCCTCGTTTCGAA
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TGACTGGCTGTTCGGGTTTTCGAGCTATGTCACCAACATCATGGACGTGATGGATAGCG
TGAACCCCGACGGAATGGCCTTCATTCCACTGAGAGTGATCCCATTCCTACGAGAGAAG
GGTATTCCACAGGAAACGCTGGCAGGCATCACTGTGACTAACCCGGCGCGGTTCTTGTC
ACCGACCTTGCGGGCGTCATGAAGCTTGCTGCGGCACTCGAGCACCACCACCACCACC
ACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGC
TGA 
 
The reference sequence contains the wtPTE gene (in italics) flanked by plasmid sequence 
(underlined). This longer sequence was used to obtain sufficient coverage at the ends of the 
gene. 
Supplementary Method S4. NGS Step 1: Raw data processing 
The processing of Illumina sequencing data shown here was performed using computational 
resources provided by University of Cambridge High Performance Computing (CSD3), but it 
can also be done on a personal computer. All scripts are available at 
https://github.com/fhlab/TRIAD. 
The first part of analysis is done by the script count.sh. Briefly, the process consists of: 
1. Assembly of paired-end reads into a single, longer read where possible, using PEAR 
v. 0.9.10 10. Through inspection of sequencing quality in FASTQ files and monitoring 
of assembly statistics, the options chosen were: 
--keep-original --min-overlap 5 --min-assembly-length 0 --quality-threshold 15 --max-
uncalled-base 0.01 
2. Create an index for the reference with Bowtie2 v.2.3.4 11 and map both assembled 
and unassembled FASTQ reads, then sort resulting SAM files with samtools v.1.9 12 
to obtain the sequencing depth. 
At this point, 95% of the reads aligned to reference sequence. 
3. Based on tags in the SAM file, extract well-mapped reads and of those only keep the 
reads that contain mutations. Since this step detects any difference from reference, it 
will contain all reads with InDels as well as reads containing single point substitutions 
from sequencing errors. Hence, the number of substitutions in the final statistics is 
over-represented. 
4. Since accurate identification of InDel position is essential for analysing transposon 
sequence preference, we use the deterministic Needleman-Wunsch algorithm to 
obtain the most accurate possible global alignment of the read to reference. Although 
using the alignment in the SAM file directly is faster, accepting a longer processing 
time at this stage is an acceptable trade-off to obtain accurate statistics of the library 
composition. The alignment was done with the Emboss 6.6.0 13 implementation 
needleall, which compares many sequences to one. 
The standard options for alignment were modified to gap open penalty 15 and gap extend 
penalty 0.5, in order to accurately identify long (9 bp or more) InDels. The default gap open 
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penalty (10) tends to split long InDels into several short InDels separated by one or two 
nucleotides. 
Alternatively, the data can also be processed on a personal computer with the following 
modification: once reads are extracted from the SAM file, they should be filtered first for those 
that contain mutations. This reduces the size of resulting fasta and alignment files, which can 
otherwise exceed >10 GB. Development and testing of the scripts were done using this 
method on Linux Mint 18 in a virtual machine with two processor cores and 3 GB RAM. The 
corresponding code is available in count_PC.sh. 
Supplementary Method S5. NGS Step 2: Parsing and statistics generation 
The following analysis is done by script PTE_composition.py implemented in Python 3 with 
the following options: 
--reference full_fragment.fa (sequence given in above in Supplementary Methods 2.3, plus 
flanking sequence from the plasmid) 
--start_offset 200 (to ignore the preceding plasmid sequence) 
--end_tail 97 
 
1. Read in all FASTA multisequence alignment generated by previous step. 
2. Create a dictionary containing all associated information: reference name, library 
name (intended as functional activity fraction or in this case, a multiplexed library), 
sequencing depth, change in DNA/protein terms, relevant counts. The information is 
nested with DNA variants nested under relevant protein variants, since multiple DNA 
variants can result in the same protein mutation. The variant information is stored 
both in internal format with a functional description 
(substitution/insertion/deletion/frameshift, used to generate statistics) and according 
to Human Genome Variation Standard. 
3. Scan each pair of sequences (reference + aligned read) from the alignment, detect 
the mutation, translate to protein and add to dictionary. 
Once the count dictionary is complete, it can be used to infer the following: 
 Number of mutations per position (DNA or protein) 
 Transposon consensus sequence for preferred insertion site 
 Composition of insertions 
 How many expected deletions/insertions (depending on the library) per DNA position are 
present 
The data analysis, code to infer statistics and resulting figures are available in 
TRIAD_composition_figures.ipynb. 
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Supplementary Method S6. Treatment of point mutations 
For reasons of computational efficiency, this pipeline focuses on reads that deviate from the 
reference. This difference may be a genuine mutation, a PCR error or a sequencing error. 
The resulting counts are therefore artificially enriched for many variants with a single 
nucleotide substitution, which each appears only once or perhaps twice. In Sanger 
sequencing (raw data not shown) we do not observe this kind of ‘background noise’, 
suggesting it should be disregarded in the NGS dataset. To corroborate this conclusion, we 
estimate the true number of point substitutions in the library by calculating the background 
substitution frequency from reads that align outside wtPTE, in the plasmid backbone, where 
no mutations were deliberately introduced during library construction. Such sequencing 
artefacts (with a single base pair substitution) occur in 3-4% of all reads, which corresponds 
to the error rate in the Illumina MiSeq NGS technology. An exact estimate is difficult due to a 
relatively low number of reads that align outside the fragment, as well as sequence 
dependence of polymerase errors – such that the error rate may be different in and out of the 
gene. Therefore, in the calculation of the proportion of frameshifts in the library, point 
mutations were simply counted as wild type (thus removing this ‘noise’).  
Supplementary Method S7. Treatment of InDel redundancy 
While pure substitution mutations can be placed very accurately, correct placement of InDels 
can be inherently ambiguous depending on the sequence context (as discussed in 1.2). 
InDels show some inherent redundancy, where distinct transposition and insertion / deletion 
events result in identical final sequence (Supplementary Figure S5B). For example, in the 
original sequence …nnGCTACTnn…, -3 bp deletions starting at position 2 (G---CT) and at 
position 3 (GC---T) result in the same final sequence: nnGCTnn (the remaining sequence 
context is abbreviated with n). The Needleman-Wunsch algorithm consistently (though 
arbitrarily) assigns this sequence to a deletion at position 2, such that any deletions 
originating from position 3 cannot be directly observed. 
Implications: 
 The raw counts that describe how many times a mutation was observed at which 
position, must be adjusted for this ambiguity, if we wish to infer the transposition 
sequence preference of the Mu transposon. The ambiguity can be partially corrected 
for deletions by generating a set of baseline reads that contain a -3 bp deletion at 
every wtPTE position and processing them in the same way as sequencing reads. 
Knowledge of these baseline counts allows us to split the observed counts in the -3 
bp library across all originating positions. Data processed in this way was the basis of 
the frequency plot in Figure 3A. 
 The diversity of mutations that can be observed is reduced compared to the maximal 
theoretical library diversity (Supplementary Figure S5). For example, in the -3 bp 
deletion library the theoretical diversity is one deletion per bp of gene length or 1000 
variants for wtPTE, but the observable diversity due to ambiguity is 748 variants 
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(based on the particular sequence of the wtPTE gene). Hence, the -3 bp deletions 
actually observed by deep sequencing at 639 positions reflect 85% (=639/748) 
coverage of all possible variants, not 64% (=639/1000). Similarly, the maximum 
diversity of insertion libraries is less than maximal theoretical diversity at DNA level is 
64 variants / triplet inserted / bp gene length. For all deletion and the +3 bp libraries, 
we calculated the theoretical diversity by computationally generating a perfect library 
(with script baseline.py), which contains every variant once (ie. 1 deletion of each 
length at each position, 1 insertion of each of the 64 codons at each positions), then 
processed this library in the same way as the NGS dataset. This shows the 
theoretical diversity in deletion libraries is ~0.75 deletion / bp gene length in wtPTE, 
while in the +3 bp library it is on average 46.22 variants / bp gene length. 
In this manuscript, we focus on discussing the observed variants, rather than the number of 
variants inferred, so the InDel redundancy is generally not corrected. The exception is the 
discussion of Mu transposon sequence preference (Figure 3A). 
Supplementary Method S8. Comparison of the effects of InDels vs. point 
substitutions on soluble expression and enzyme activity  
Two TRIAD libraries (-3 bp and +3 bp) and the TriNEx library were transformed into E. coli 
BL21(DE3) (not containing pGro7). Overall, 192 transformants (corresponding to 40 deletion 
variants, 76 insertions variants and 76 substitution variants) were randomly picked and their 
plasmids were subjected to Sanger sequencing to discard frameshifted variants. As a result, 
30 deletion, 27 insertion and 30 substitution variants were selected for further analysis of 
soluble expression and enzyme activity. The corresponding cells were transferred into 96-
deep well plates for growth and expression as described in the Methods section of the main 
text. Paraoxonase activity was measured in diluted (1:1000 and 1:100) cell lysates (soluble 
fraction) as described there. Changes in soluble expression levels relative to parent wtPTE 
were determined by SDS-PAGE analysis of the soluble fractions. The OD600 was used to 
normalize the amount to analyse by SDS-PAGE for each sample. To determine the soluble 
expression change relative to the parent for each variant, the intensity of the protein band of 
interest was measured using ImageJ and standardized against that of wtPTE.  
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SUPPLEMENTARY FIGURES 
 
 
 
Supplementary Figure S1 (Continued on next page, legend follows). 
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(Figure S1 continued) 
 
 
 
Supplementary Figure S1 (Continued on next page, legend follows). 
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(Figure S1 continued) 
Supplementary Figure S1. Schematic outline and timeline of the procedure for the 
generation of random InDel libraries 
A. Generation of deletion libraries.  
Step 1: The TransDel insertion library is generated by in vitro transposition of the engineered 
transposon TransDel into the plasmid containing the target gene followed by the subcloning of 
the fragment comprising the target gene and the transposon into a fresh plasmid.  
Step 2: MlyI digestion removes TransDel together with 3 bp of the original target gene and 
generates a single break per target gene variant.  
Step 3a: Intramolecular ligation results in the reformation of the target gene minus 3 bp, 
yielding a library of single variants with a deletion of 1 triplet 1.  
Step 3b: DNA cassettes dubbed Del2 and Del3 are then inserted between the break in the 
target gene to generate Del2 and Del3 insertion libraries.  
Step 4b: MlyI digestion removes Del2 and Del3 together with 3 and 6 additional bp of the 
original GOI, respectively.  
Step 5b: Intramolecular ligation results in the reformation of the target gene minus 6 and 9 bp, 
yielding libraries of single variants with a deletion of 2 and 3 triplets, respectively. Red vertical 
lines indicate deletions. 
B. Generation of insertion libraries.  
Step 1: The TransIns insertion library is generated by in vitro transposition of the engineered 
transposon into the target gene.  
Step 2: digestion by NotI and MlyI removes TransIns.  
Step 3: DNA cassettes dubbed Ins1, Ins 3 and Ins3 (with respectively 1, 2 and 3 randomized 
bp triplets at one of their extremities; indicated in blue) are then inserted between the break in 
the target gene to generate the corresponding Ins1, Ins2 and Ins3 insertion libraries.  
Step 4: AcuI digestion and 5’end digestion by the Klenow fragment remove the cassettes, 
leaving the randomized triplet(s) in the original target gene.  
Step 5: Intramolecular ligation results in the reformation of the target gene plus 3, 6 and 9 
random bp, yielding libraries of single variants with an insertion of 1, 2 and 3 triplets, 
respectively. Purple vertical lines indicate insertions. 
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Supplementary Figure S2 (Continued on next page, legend follows). 
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(Figure S2 continued) 
 
 
Supplementary Figure S2 (Continued on next page, legend follows). 
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(Figure S2 continued) 
 
 
 
Supplementary Figure S2. Engineered transposons and cloning cassettes used in 
TRIAD. 
Sequences of (A) Mu transposons TransDel and TransIns, (B) deletion cassettes Del2 and 
Del3, (C) insertion cassettes Ins1, Ins2 and Ins3 (n = 1, 2 or 3 nucleotide triplets), (D) Maps of 
vectors pUC-57-TransDel, -TransIns, -Del2/3, -Ins1/2/3.  Note that in (C) the location of the 
KanR gene vs the NNN codons is identical to the depiction in Fig. 2B (where the restriction 
sites appear flipped around), but in both cases NNN codons appear next to the MlyI 
restriction site, which is upstream of the KanR expression cassette.  
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Supplementary Figure S3: Sequence of the synthetic wtPTE gene and its 
corresponding protein product 
This gene was designed without MlyI, AcuI and NotI restriction sites and cloned into pID-Tet 
or pET-strep vectors using NcoI and HindIII (underlined). Start and stop codons are shown in 
bold. The resulting protein (in red) was expressed in fusion with a Strep-tag II peptide (shown 
in green) at its N-terminus and its sequence corresponds to the one referred to as PTE-R0 in 
14, 15 and as wtPTE in 8, 16. Residues were numbered according to PDB 4PCP. 
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Supplementary Figure S4 (Continued on next page, legend follows). 
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(Figure S4 continued) 
 
 
Supplementary Figure S4: Vectors for the generation of InDel variant libraries 
These vectors are designed for the construction of TRIAD libraries and expression of the 
generated variants (feature not used in the present study). They were designed and 
assembled (see supplementary methods) from different components separated by three 
restriction sites: (i) ampicillin resistance gene (AmpR; AatII/SpeI) forming an operon with TetR 
(encoding the tetracycline repressor) in the case of pID-Tet, (ii) origin of replication (ori; 
SpeI/AflII), and (iii) expression cassette (AflII/AatII) consisting of a promoter (T7 and Tet for 
pID-T7 and pID-Tet, respectively), a multiple cloning site (MCS), sequences encoding affinity 
tags (i.e. Strep-tag II and 6xHis-tag) and the T7 terminator sequence. These vectors do not 
contain any MlyI, AcuI and NotI restriction sites in their sequence. (A) Maps of vector pID-T7 
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and pID-Tet. (B) Map and sequence of expression cassette for pID-T7, where position T8 of 
the T7 promoter was mutated to C to remove MlyI site as in 9. (C) Map and sequence of 
expression cassette for pID-Tet. (D) Map and sequence of AmpR cassette (silent mutations to 
remove AcuI and FokI sites are indicated). 
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Supplementary Figure S5: Theoretical diversities of the InDel libraries obtained with 
TRIAD 
(A) This plot shows the theoretical diversity per transposon insertion site within the target 
gene for each type of InDel generated using TRIAD. Only one deletion, regardless of its 
length, can occur at a given transposition insertion site. Conversely, insertion diversity is 
related to the length of the randomized inserted triplet nucleotides (43, 46 and 49 for one, two 
and three triplet insertions, respectively). Transposon insertion can occur at each position of 
the target DNA, providing it does not affect the restriction sites that are necessary in the 
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various subcloning steps of the TRIAD procedure. Therefore, the theoretical diversity for each 
TRIAD library is obtained by multiplying the values plotted in this figure with the length of the 
target DNA. In the case of a target gene with the length of wtPTE (~1,000 bp), the theoretical 
diversity for deletion libraries is ~103 while it is 6.4x104, ~4.1x106 and ~2.6x108 for one, two 
and three triplet insertions, respectively. (B) Examples of InDel redundancy in the case of 
deletions (-3 bp) or insertions (+3 bp) of a triplet resulting in the same DNA variants. (C) 
Theoretical diversities accessible by applying TRIAD to the wtPTE gene sequence in TRIAD 
libraries -3, -6, -9, +3 and +6 bp. The diversities were determined computationally by using 
the python script baseline.py to generate fasta reads with all possible mutations, which were 
then aligned and counted in the exact same way as the physical libraries. 
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Supplementary Figure S6 (legend next page) 
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Supplementary Figure S6: Sequencing coverage in the NGS of the TRIAD libraries of 
wtPTE. 
The final total depth from all assembled and unassembled reads that map to the reference is 
shown along the entire sequencing fragment. The proportion of reference DNA corresponding 
to wtPTE gene is shown on shaded background. Coverage for insertion libraries is 
approximately 3× that of deletion libraries, due to higher loading onto the MiSeq flow-cell in 
order to capture the higher diversity of insertion libraries better. Despite a decrease in 
coverage around position 200, good coverage is maintained across the entire wtPTE gene. 
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Supplementary Figure S7 (legend next page) 
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Supplementary Figure S7: Distribution of observed number of reads per mutation. 
The histograms show how many mutations are observed once, twice, thrice, ten times or 
more. In deletion libraries we find that most mutations detected are supported by 10-40 
observations (each observation is a single read in raw sequencing data). 
The bias of transposon site preference results in InDels being observed more often at some 
positions than other. In the deletion libraries, most mutations are supported by < 50 reads 
(see Table S6), but there is a long tail generated by positions that are close to the Mu 
transposon consensus – this is aggregated into one bin in the histograms in this Figure for 
clarity. Because of the large diversity of insertion libraries, variants are generally observed 
with lower frequencies (x-axis) compared to the deletion libraries.  
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Supplementary Figure S8 (Continued on next page, legend follows). 
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(Figure S8 continued) 
B 
 
Supplementary Figure S8 (legend next page) 
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Supplementary Figure S8: Number of distinct insertions observed per position in 
wtPTE. 
(A) Distribution and number of distinct (or unique) insertions per DNA position determined by 
deep sequencing in +6 bp and + 9 bp bp libraries., compared to the mean per position.In 
analogy to Figure 3C in the main text, this figure shows the number of observed insertions at 
each position where mutations are observed. The possible diversity of +6 bp and +9 bp 
insertions is much higher than for +3 bp library, which results in more pronounced high 
diversity “spiked” at positions where transposon insertion is favoured. The horizontal line 
shows the mean number of observed insertions per position (105 and 102 for +6 bp and +9 
bp, respectively). These results are not corrected for codon ambiguity, which increases the 
unevenness of the distribution. 
(B) Distribution of the number of positions in the gene encoding wtPTE versus the number of 
distinct insertions observed by deep sequencing.  
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Supplementary Figure S9: Distribution of nucleotide bases in the randomized inserts 
of the +3, +6 and +9 bp libraries 
The nucleotide percentage distributions of the in-frame insertions observed among all wtPTE 
variants observed during deep sequencing. Every detected insertion contributes equally to 
this distribution, regardless of frequency in the library. 
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Supplementary Figure S10: Relationship between mutational tolerance and solvent-
accessible surface area (SASA) in wtPTE 
The solvent accessible surface area (SASA) of residues mutated (either InDel or substitution) 
in wtPTE variants retaining ≥50% of the parental paraoxonase activity was calculated from 
the structure of wtPTE (PDB code: 4PCP) using the PISA web server at the European 
Bioinformatics Institute (http://www.ebi.ac.uk/pdbe/prot_int/pistart.html) 17. Relative accessible 
surface area (RSA) was defined as the ratio of the SASA for a given residue within the 
structured protein vs. in the free residue 18. Residues were classified as core for RSA < 0.25, 
and surface for RSA ≥ 0.25 19. Mutated residues are listed in Supplementary Table S10.
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Supplementary Figure S11: Comparison of the effects on activity and solubility (i.e., kinetic stability) between InDel (from TRIAD libraries -3 bp 
and +3 bp) and substitution variants (from TriNEx library) of wtPTE. 
Upon transformation of the DNA libraries into E. coli BL21(DE3), a total of 192 colonies (64 per library) were selected randomly, and their corresponding PTE 
variants sequenced to discard the ones with frameshifting mutations. The appropriate number of variants with non-frameshifting mutations were then 
screened for phosphotriesterase activity and soluble expression in the absence of GroEL/ES.Changes in paraoxonase (PTE) activity are determined relative 
to those of wtPTE by comparing the initial rates in cell lysates measured under identical conditions with 200 µM of the native paraoxon substrate (see 
Methods section and Tables S11-12). Relative soluble expression levels are determined as the ratio in protein expression levels in the clear lysate 
(supernatant) between variants and the parent enzyme wtPTE measured by SDS-PAGE (See Methods and Tables S11-12).  
Deletions (-3 bp) Insertions (+3 bp) Substitutions
Strongly destabilizing
Mildly destabilizing
Neutral
Strongly destabilizing
Mildly destabilizing
Neutral
Strongly destabilizing
Mildly destabilizing
Neutral
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Supplementary Figure S12: Activity trade-offs in wtPTE InDel variants improved in 
arylesterase activity. 
Activity trade-offs among InDel wtPTE variants improved in arylesterase activity (AE) hits 
(Supplementary Table S13) were evaluated by calculating the specificity ratio, i.e. the ratio 
between the level of AE activity in cell lysate and that of phosphotriesterase activity (PTE). 
This plot shows the specificity ratio for each InDel variants listed in Supplementary Table S13. 
The average (~260) and median (~17) specificity ratios are also indicated. 
 
 
  
10
0
10
1
10
2
10
3
10
4
10
5
AE hits
S
p
e
c
if
ic
it
y
 r
a
ti
o
 (
A
E
 /
 P
T
E
)
 
263
17
  
SI-38 
 
Supplementary Figure S13: Insertions and deletions improving the arylesterase 
activity of wtPTE by > 2-fold. 
(A) Location and occurrence of adaptive insertions and deletions in wtPTE. InDels 
improving arylesterase activity (AE) towards 4-nitrophenyl butyrate (4-NPB; top plot) and 2-
naphthyl hexanoate (2-NH; bottom plot) are shown according to their location in the wtPTE 
sequence and the number of their occurrences.  
(B) Average and median activity change in AE-improved wtPTE variants. Values refer to 
the activity change of all AE-improved variants relative to wtPTE obtained by comparing the 
initial rates v0 for the hydrolysis of paraoxon (PTE), 4-NPB or 2-NH to that of wtPTE at 200 
μM substrate concentration, resulting in a dimensionless ratio. The average change value 
was determined as the geometric mean of the relative activities of the variants listed in 
Supplementary Table S13 and the median change corresponds to the relative activity lying at 
the midpoint of the recorded relative activities.  
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Supplementary Figure S14: Soluble and insoluble expression of PTE hits in the 
presence and absence of GroEL/ES chaperones. 
Screening of InDel (TRIAD) libraries of wtPTE variants for increased arylesterase activity was 
performed in the presence of co-expressed GroEL/ES chaperones to buffer destabilizing and 
adaptive mutations. A comparison of PTE expression in E. coli lysates (P: pellet; S; soluble 
fraction) of the parent wtPTE and four characterized hits (see Table 3) shows slight increases 
of PTE expression in the presence of chaperone (see Table S14 for a quantitation of the band 
intensity). These suggest that the inclusion of GroEL/ES chaperones was helpful, but not 
crucial for the success of the experiment. The gels images are a representative 
representation of an experiment conducted in triplicate. 
 Supplementary Figure S15 (Continued on next page, legend follows) 
(A)   PTE      AE 
∆A270L271L272G273 
  
P256R/G256aA256b 
  
S256aG256b 
 
  SI-41  
  PTE       AE 
G311a 
  
 
(B) 
  
 
Supplementary Figure S15: Kinetic characterization of InDel wtPTE variants with 
improved arylesterase activity. 
(A) Michaelis-Menten plots for purified AE InDel hits. Phosphotriesterase (PTE; substrate: 
paraoxon) and arylesterase (AE; substrate: 2-Naphthyl Hexanoate) activities were measured in 
triplicates and error bars show standard deviation. Conditions: [S]=0–2 mM; [Tris-HCl] = 100 mM 
(pH 7.5); [ZnCl2] = 200 µM; Enzyme concentrations: for PTE activity, [Enzyme] = 5 (for 
P256R/G256aA256b and G311a) or 10 nM (for ∆A270L271L272G273 and S256aG256b); for AE 
activity, [Enzyme] = 200 nM (for ∆A270L271L272G273, P256R/G256aA256b and S256aG256b) 
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or 20 nM (for G311a); T = 25 °C. KM and kcat were determined by fitting the initial rates (V0) at 
each concentration to the Michaelis-Menten model using KaleidaGraph (Synergy Software). 
(B) Correlation between activities measured in cell lysate and using purified enzyme for 
variants selected for improved arylesterase activity. All measurements were performed at 200 
μM substrate. Activities in cell lysate (enzyme co-expressed with GroEL/ES) are given relative to 
wtPTE (see SupplementaryTable S13). Kinetic data for wtPTE and variant H254R had been 
previously reported 8, 14.  
 
  43 
wtPTE: Tm 78.1 ± 0.2°C 
 
∆A270L271L272G273: Tm 82 ± 1°C 
 
P256R/G256aA256b: Tm 84.3 ± 0.3°C 
Supplementary Figure S16 (Continued on next page, legend follows). 
(Figure S16 continued) 
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S256aG256b: Tm 77.5 ± 0.4°C & 85.6 ± 0.2°C 
 
G311a: Tm 75.2 ± 0.3°C 
 
Supplementary Figure S16: Tm measurement of wtPTE and four selected hits 
Thermostability of five purified proteins was measured using BioRad CFX Connect real-time 
PCR instrument by monitoring the binding of SYPRO Orange dye to unfolded protein. The 
sample solutions were equilibrated at 25°C for 15 minutes, then the temperature was raised 
to 95 °C in 0.5 °C increments with 30 s equilibration per increment. Plots on the left hand side 
show the fluorescence trace for each variant and right plots the first derivative with respect to 
time. The charts include data from all wells with a defined melting curve, which were obtained 
while screening multiple protein and SYPRO dye concentrations, resulting in different signal 
intensity between conditions. The results are given as mean ± standard deviation. 
 
  
 
 
 
 
Supplementary Figure S17 (Continued on next page, legend follows). 
 
(Figure S17 continued) 
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Supplementary Figure S17: Application of TRIAD for the generation of focused InDel 
libraries.  
(A) Schematic outline of the procedure for the generation of focused InDel libraries. 
Transposon (i.e., TransDel or TransIns) insertion is carried out on a plasmid containing only 
the target sequence, ‘shielding’ the rest of the gene from transposon integration. Target 
sequences are excised by SapI digestion, and those containing the inserted transposon 
(Figure S17 continued) 
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purified by virtue of their larger size. These fragments can subsequently be cloned into a 
‘SapI-adapter’ plasmid, re-forming the whole gene; now containing transposon only in the 
target region. Finally, InDel mutagenesis is achieved following the cloning steps illustrated in 
Figure 1 and Figure S1. 
(B) Mechanism for the cloning of focused transposon insertion libraries by seamless cloning 
using the type IIS restriction enzyme SapI. Seamless cloning with SapI allows cloning the 
target sequence without altering the original DNA sequence of the gene of interest. In the 
illustrated example, sequences flanking the target region (TGC and ATG) belong to the gene 
of interest. Upon digestion with SapI cohesive ends are generated to enable the seamless 
fusion of the target sequence (containing the inserted transposon) within its original gene 
sequence. Note that SapI is used here as an example and that any other analogous type IIS 
restriction enzyme (e.g., BsaI or FokI) could be used to achieve this strategy. 
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SUPPLEMENTARY TABLES 
 
Supplementary Table S1. Mutagenesis efficiency of TRIAD – individual variants 
Libraries were generated from wtPTE. Upon the final transformation step, randomly chosen variants were sequenced by the Sanger method (see also 
Supplementary Tables S2-3). In-frame InDels (i.e., InDels of multiple of three nucleotides) can result in adjacent substitutions (enumerated in the “InDels with 
adjacent substitution” sub-category) depending on the insertion point of the transposon. The number of unique sequences was recorded among the observed 
correct sequences. The Unique sequences sub-category refers to in-frame InDels that are observed at least once (see also Supplementary Table S3). 
 
  
Deletions 
 
Insertions 
  
Library 
 
-3 bp -6 bp -9 bp All deletions 
 
+3 bp +6 bp +9 bp All insertions 
 
All Indels 
Total number of sequenced variants 
 
21 21 22 64 (100%) 
 
23 16 18 57 (100%) 
 
121 (100%) 
In-frame InDels 
 
21 17 17 55 (86%) 
 
11 12 12 35 (61%) 
 
90 (74%) 
InDels with no adjacent substitution 
 
17 12 9 38 (59%) 
 
7 10 8 25 (44%) 
 
63 (52%) 
InDels with adjacent substitution 
 
4 5 8 17 (27%) 
 
4 2 4 10 (18%) 
 
27 (22%) 
Unique sequences 
 
20 17 17 54 (84%) 
 
11 12 12 35 (61%) 
 
89 (74%) 
Frameshifting InDels 
 
0 4 5 9 (14%) 
 
12 4 6 22 (39%) 
 
31 (26%) 
 
  
Supplementary Table S2. Sequence analysis of naïve InDel libraries of wtPTE 
obtained with TRIAD. 
Sequences were determined from randomly chosen variants upon generation of the libraries. 
Residues are numbered according to the crystal structure of wtPTE (PDB: 4PCP). The 
symbol ∆ before a residue (or a group of residues) signifies that this (or these) residue(s) 
have been deleted. Inserted residues are labelled using the number of the position after 
which they are inserted and alphabetical order (e.g., glutamine and tyrosine residues inserted 
in this order after the residues at position 230 would be labelled Q230aY230b). 
 
Library 
Variant 
number 
DNA change 
Length 
change (bp) 
Protein mutation 
-3 bp 1 A(TGG)C -3 ∆G157 
 
2 A(GGA)A -3 ∆E144 
 
3 T(TGC)G -3 L66C/∆R67 
 
4 C(CAC)A -3 ∆H230 
 
5 G(GCG)A -3 ∆A126 
 
6 C(CGG)G -3 ∆R189 
 
7 T(TCG)A -3 F104Y/∆D105 
 
8 G(CTA)T -3 ∆Y309 
 
9 A(TGA)A -3 ∆M293 
 
10 G(TCT)A -3 ∆L262 
 
11 A(AGA)T -3 ∆E263 
 
12 C(TGG)G -3 L272R/∆G273 
 
13 G(CCG)A -3 ∆A114 
 
14 C(TGA)G -3 ∆L330 
 
15 C(GGG)C -3 R280P/∆A281 
 
16 C(TAC)G -3 ∆L336 
 
17 T(CTA)G -3 ∆L252 
 
18 G(GAG)T -3 ∆E181 
 
19 C(TAC)A -3 ∆Y292 
 
20 C(TAC)A -3 ∆Y292 
 
21 A(TGG)G -3 ∆M33 
-6 bp 1 AAT(GACTGGC)TGT -7 frameshift 
 
2 TCC(GAGGGCT)TGAG -7 frameshift 
 
3 ATC(ATGGAC)GTG -6 ∆M314D315 
 
4 CAA(TACCGT)GCG -6 N38K/∆T39K40 
 
5 TAA(CCACTC)ACA -6 T199N/∆T200H201 
 
6 AGG(CTACAT)GAA -6 ∆Y292M293 
 
7 CCA(CTGAGA)GTG -6 ∆L330R331 
 
8 TCG(TGGCAA)ACA -6 ∆W277Q278 
 
9 TCG(CGGGCT)GCC -6 ∆R118A119 
 
10 CGG(TAACCACTCAC)ACG -11 frameshift 
 
11 GAT(AATGCG)AGT -6 ∆N265A266 
 
12 ATT(CCTACG)AGA -6 F335L/∆L336R337 
 
13 GAC(TAACCC)GGC -6 ∆N353P354 
(Table S2 continued) 
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Library 
Variant 
number 
DNA change 
Length 
change (bp) 
Protein mutation 
 
14 AAT(CCGAGG)GCT -6 S218C/∆E219G220 
 
15 GAG(GAGTGT)AGA -6 ∆S142V143 
 
16 GTG(CGCGGT)CCT -6 ∆R41G42 
 
17 TTG(GCCGGA)GTT -6 ∆P70E71 
 
18 AAC(CCCGAC)GGA -6 ∆P322D323 
 
19 TCC(GAGGGC)TTG -6 ∆E219G220 
 
20 GGT(GTTCCGG)TAA -7 frameshift 
 
21 ACC(CGGCGC)GGT -6 P354R/∆A355R356 
-9 bp 1 CCC(TCACGGGTTT)GTA -10 frameshift 
 
2 CGT(TCGTGGCAA)ACA -9 ∆S276W277Q278 
 
3 CTT(CCTGCGTGA)GAT -9 F150L-∆L151R152E153 
 
4 AAA(AGGCTGTGA)GAG -9 ∆K82A83V84 
 
5 AAC(ATCATGGAC)GTG -9 ∆I313M314D315 
 
6 ATT(CCACTGAGA)GTG -9 ∆P329L330R331 
 
7 CAG(CTCGGCAGG)ATT -9 S61R/∆S62A63G64 
 
8 GCA(AGTCAGCGC)GGT -9 ∆S205Q206R207 
 
9 CGA(CCACAGGCA)AGG -9 ∆T172T173G174 
 
10 ACC(GGCTTGTGG)CTC -9 ∆G129L130W131 
 
11 AAG(GGCGGCCGC)CCG -9 R185S/∆A186A187A188 
 
12 GCCCC -> GAATTC +1 frameshift 
 
13 TCA(TCGACCAAG)GCT -9 I288S/∆D289Q290G291 
 
14 CCT(CCATGGGCG)ATC -9 S32Y/∆M33G34D35 
 
15 CTC(TAGCGGAAA)AGG -9 L79Q/∆A80E81K82 
 
16 GTT(TCGCGGGCTG)CCG -10 frameshift 
 
17 CGA(TTGGTCTAG)AAG -9 I260K/∆G261L262E263 
 
18 TCA(AGGCGCTCA)TCG -9 K285M/∆A286L287I288 
 
19 GAT(CTCGGTCGC)GAC -9 ∆L106G107R108 
 
20 C(TCG)C -3 L243P/∆A244 
 
21 GCT(GCGCGCGGAT)ACC -10 frameshift 
 
22 GAT(ACTGACGAT)TTG -9 ∆T234D235D236 
+3 bp 1 TT+C GG+G CGC +3 L87F/G87a 
 
2 TT+G TT+A GTG +3 L182a 
 
3 TCCTAT+TT+CACAAT +2 frameshift 
 
4 CTA +CGA+ GAA +3 R262a 
 
5 TGGCA -> TTTA -1 frameshift 
 
6 GA+C AT+G GAA +3 E144D/M144a 
 
7 ACG -> AGGTG +2 frameshift 
 
8 TCG +ACT+ TGG +3 T276a 
 
9 ACC+AT+CGG +2 frameshift 
 
10 TT+A CC+C CTG +3 F150L/P150a 
 
11 CCGA -> CACGGA +2 frameshift 
 
12 AGA+CT+GGA +2 frameshift 
 
13 TTC+T+CGG +1 frameshift 
 
14 AA+A TA+T ACC +3 N38K/Y38a 
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Library 
Variant 
number 
DNA change 
Length 
change (bp) 
Protein mutation 
 
15 GGT+AA+CTA +2 frameshift 
 
16 ATTG -> AATATG +2 frameshift 
 
17 GGT +GTT+ CTA +3 V261a 
 
18 ACC +TTC+ CAC +3 F54a 
 
19 GG+A TT+C ATC +3 F157a 
 
20 TAG+GA+AAG +2 frameshift 
 
21 GAT +AAT+ GAT +3 N232a 
 
22 TCT+AC+CCG +2 frameshift 
 
23 TGT -> TTTT +1 frameshift 
+6 bp 1 GG+G GGG AT+C +6 G229aI229b 
 
2 TGG +ATG TTT+ CCG +6 M69aF69b 
 
3 CAG +AAT CTG+ GAA +6 N343aL343b 
 
4 TCC +CAG AGT+ GAG +6 Q47aS47b 
 
5 A+AT GAA C+TC +6 I44N/E44aL44b 
 
6 C+GG ATC C+CC +6 R177aI177b 
 
7 ACC+TCGTC+GGT +5 frameshift 
 
8 CG+G AAA TA+C +6 K76aY76b 
 
9 CC+G ATG CC+C +6 M178aP178b 
 
10 GGC +GTT AGC+ TAC +6 V291aS291b 
 
11 GG+G TTA AC+C +6 L157aT157b 
 
12 TGG +GGT GTA+ CCG +6 G69aV69b 
 
13 see note [1] -61 frameshift 
 
14 T+GG TTC G+TG +6 L66W/F66aV66b 
 
15 CCA+GGTAT+CAG +5 frameshift 
 
16 TTA+GTGGC+TCA +5 frameshift 
+9 bp 1 GCC+GTAAGGTT+CAG +8 frameshift 
 
2 ACC +GAT TAA TGC+ CAC +9 D54a - Stop 
 
3 GCT +TGT TGT CCT+ CTC +9 C281aC281bP281c 
 
4 GA+A AGC TAT GA+G GAA +9 S144aY144bE144c 
 
5 GTC+CCCACGTCT+CGA +8 frameshift 
 
6 CTG+GGGTATGG+CGT +8 frameshift 
 
7 TC+A TAT GGA AT+C +9 Y218aG218bI218c 
 
8 GGT+CCTCTGGG+TTG +8 frameshift 
 
9 CG+G GTG TGT CG+CA +9 V76aC76bR76c 
 
10 GA+A ACT GCA AA+C +9 
D235E/T235aA235bN235
c 
 
11 G+GA TCG TGG T+CC +9 A90G/S90aW90bS90c 
 
12 CC+A GAG ACC GT+G +9 E256aT256bV256c 
 
13 C+CG AGT TGA T+TG +9 L330P/S330a - Stop 
 
14 CA+G GGT GGT AT+C +9 H57Q/G57aG57bI57c 
 
15 TAC +ATC GTT TCG+ ATG +9 I292aV292bS292c 
 
16 TCA+CCCGTCT+CGG +7 frameshift 
 
17 GG+A ACA GTG CG+T +9 T273aV273bR273c 
 
18 ATG+CTTTGGGG+GCA +8 frameshift 
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[1] This variant showed a large sequence substitution where CCATGGGCGAT-
CGGATCAATACCGTGCGCGGTCCTATCACAATCTCCGAGGCGGGTTTCACACTAACCC 
(modified sequence in bold) was exchanged for CTCCAGGC (in bold), resulting in a 61 bp 
deletion. 
  
Supplementary Table S3. Frequency of in-frame InDels observed among randomly 
sequenced wtPTE variants (as recorded in Table S2). 
Residues are numbered according to the crystal structure of wtPTE (PDB: 4PCP). 
Protein position Observed InDel Library Frequency 
Variant 
name 
32 S32Y/∆M33G34D35 -9 bp 1 15 
33 ∆M33 -3 bp 1 21 
38 N38K/∆T39K40 -6 bp 1 4 
38 N38K/Y38a +3 bp 1 14 
41 ∆R41G42 -6 bp 1 18 
44 I44N/E44aL44b +6 bp 1 5 
47 Q47aS47b +6 bp 1 4 
54 F54a +3 bp 1 19 
54 D54a - Stop +9 bp 1 2 
57 H57Q/G57aG57bI57c +9 bp 1 16 
61 S61R/∆S62A63G64 -9 bp 1 8 
66 L66C/∆R67 -3 bp 1 3 
66 L66W/F66aV66b +6 bp 1 17 
69 M69aF69b +6 bp 1 2 
69 G69aV69b +6 bp 1 14 
70 ∆P70E71 -6 bp 1 19 
76 K76aY76b +6 bp 1 9 
76 V76aC76bR76c +9 bp 1 9 
79 L79Q/∆A80E81K82 -9 bp 1 16 
82 ∆K82A83V84 -9 bp 1 4 
87 L87F/G87a +3 bp 1 1 
90 A90G/S90aW90bS90c +9 bp 1 11 
104 F104Y/∆D105 -3 bp 1 7 
106 ∆L106G107R108 -9 bp 1 20 
114 ∆A114 -3 bp 1 13 
118 ∆R118A119 -6 bp 1 9 
126 ∆A126 -3 bp 1 5 
129 ∆G129L130W131 -9 bp 1 11 
142 ∆S142V143 -6 bp 1 17 
144 ∆E144 -3 bp 1 2 
144 E144D/M144a  +3 bp 1 6 
144 S144aY144bE144c +9 bp 1 4 
150 F150L/∆L151R152E153 -9 bp 1 3 
150 F150L/P150a +3 bp 1 10 
157 ∆G157 -3 bp 1 1 
157 F157a +3 bp 1 20 
157 L157aT157b +6 bp 1 12 
172 ∆T172T173G174 -9 bp 1 10 
177 R177aI177b +6 bp 1 7 
178 M178aP178b +6 bp 1 10 
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Protein position Observed InDel Library Frequency 
Variant 
name 
181 ∆E181 -3 bp 1 18 
182 L182a +3 bp 1 2 
185 R185S/∆A186A187A188 -9 bp 1 12 
189 ∆R189 -3 bp 1 6 
199 T199N/∆T200H201 -6 bp 1 5 
205 ∆S205Q206R207 -9 bp 1 9 
218 S218C/∆E219G220 -6 bp 1 16 
218 Y218aG218bI218c +9 bp 1 7 
219 ∆E219G220 -6 bp 1 22 
229 G229aI229b +6 bp 1 1 
230 ∆H230 -3 bp 1 4 
232 N232a +3 bp 1 22 
234 ∆T234D235D236 -9 bp 1 23 
235 D235E/T235aA235bN235c +9 bp 1 10 
252 ∆L252 -3 bp 1 17 
256 E256aT256bV256c +9 bp 1 12 
260 I260K/∆G261L262E263 -9 bp 1 18 
261 V261a +3 bp 1 17 
262 ∆L262 -3 bp 1 10 
262 R262a +3 bp 1 4 
263 ∆E263 -3 bp 1 11 
265 ∆N265A266 -6 bp 1 13 
272 L272R/∆G273 -3 bp 1 12 
273 T273aV273bR273c +9 bp 1 19 
276 ∆S276W277Q278 -9 bp 1 2 
276 T276a +3 bp 1 8 
277 ∆W277Q278 -6 bp 1 8 
280 R280P/∆A281 -3 bp 1 15 
281 C281aC281bP281c +9 bp 1 3 
285 K285M/∆A286L287I288 -9 bp 1 19 
288 I288S/∆D289Q290G291 -9 bp 1 14 
291 V291aS291b +6 bp 1 11 
292 ∆Y292 -3 bp 2 19, 20 
292 ∆Y292M293 -6 bp 1 6 
292 I292aV292bS292c +9 bp 1 17 
293 ∆M293 -3 bp 1 9 
309 ∆Y309 -3 bp 1 8 
313 ∆I313M314D315 -9 bp 1 5 
314 ∆M314D315 -6 bp 1 3 
322 ∆P322D323 -6 bp 1 21 
329 ∆P329L330R331 -9 bp 1 6 
330 ∆L330 -3 bp 1 14 
330 ∆L330R331 -6 bp 1 7 
330 L330P/S330a - Stop +9 bp 1 14 
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Protein position Observed InDel Library Frequency 
Variant 
name 
335 F335L/∆L336R337 -6 bp 1 14 
336 ∆L336 -3 bp 1 16 
343 N343aL343b +6 bp 1 3 
353 ∆N353P354 -6 bp 1 15 
354 P354R/∆A355R356 -6 bp 1 24 
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Supplementary Table S4A: Deep sequencing coverage statistics. 
All six libraries were sequenced as part of one MiSeq 2×75 bp run. Since insertion libraries 
have a greater theoretical diversity, they were loaded onto the flow cell at 3× the amount of 
deletion libraries. 
 
Library  -3 bp -6 bp -9 bp 
Total reads  1.04×106 1.09×106 8.99×105 
Assembled reads  7.50×105 8.22×105 6.48×105 
Alignment rate  96.4% 95.1% 90.3% 
Unassembled reads  2.86×105 2.67×105 2.51×105 
Alignment rate  93.5% 95.9% 88.6% 
Total aligned reads  9.90×105 1.04×106 8.07×105 
Mean ± SD coverage 
per base 
 (8.59±1.7)×104 (8.84±1.7)×104 (6.99±1.6)×104 
 
 
Library  +3 bp +6 bp +9 bp 
Total reads  3.36×106 3.38×106 3.09×106 
Assembled reads  2.56×106 2.51×106 2.47×106 
Alignment rate  97.1% 95.0% 95.8% 
Unassembled reads  8.08×105 8.67×105 6.28×105 
Alignment rate  96.6% 94.0% 95.6% 
Total aligned reads  3.27×106 3.20×106 2.968×106 
Mean ± SD coverage 
per base 
 (2.76±0.54)×105 (2.73±0.58)×105 (2.38±0.45)×10
5 
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Supplementary Table S4B: Proportion of frameshifts 
The proportion of variants containing frameshifts was estimated as follows: 
 
𝐸𝑠𝑡. % 𝑓𝑟𝑎𝑚𝑒𝑠ℎ𝑖𝑓𝑡𝑒𝑑 𝑣𝑎𝑟𝑖𝑎𝑛𝑡𝑠 =  
𝑓𝑟𝑎𝑚𝑒𝑠ℎ𝑖𝑓𝑡 𝑟𝑒𝑎𝑑𝑠 𝑎𝑙𝑙 𝑟𝑒𝑎𝑑𝑠⁄
𝑟𝑒𝑎𝑑 𝑙𝑒𝑛𝑔𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑔𝑒𝑛𝑒⁄
 
 
Where read length is equal to 2×75=150 bp and the gene length is 999 bp. 
 
 
Deletions 
Sequencing reads -3 bp -6 bp -9 bp 
All reads 9.90×10
5 1.04×106 8.07×105 
Reads with target mutations 74923 48911 42358 
% with target mutations 7.6% 4.7% 5.3% 
Reads with frameshifts 6082 30813 17163 
% of reads with frameshifts 0.6% 3.0% 2.1% 
Est. % frameshifted variants 4.1% 19.8% 14.2% 
 
 
 
Insertions 
Sequencing reads +3 bp +6 bp +9 bp 
All reads 3.27×10
6 3.20×106 2.968×106 
Reads with target mutations 121089 145374 115899 
% with target mutations 3.7% 4.5% 3.9% 
Reads with frameshifts 179412 139738 117505 
% of reads with frameshifts 5.5% 4.4% 4.0% 
Est. % frameshifted variants 36.6% 29.1% 26.4% 
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Supplementary Table S5: TransDel consensus site preference 
(see WebLogo in Figure 3A) 
Mu transposons insert within a five-nucleotide sequence, which is duplicated during the 
insertion. The insertion preference of TransDel in wtPTE gene can be calculated with 
precision from the location of -3 bp deletions, because these deletions are symmetrical and 
centred within the insertion site. The consensus site preference is built from detected -3 bp 
mutations, weighed according to frequency of occurrence and adjusted for orientation of 
transposon and GC composition. 
 
Position A C G T 
1 14.4% 34.4% 25.7% 25.5% 
2 12.4% 38.3% 17.7% 31.7% 
3 16.5% 33.5% 33.5% 16.5% 
4 31.7% 17.7% 38.3% 12.4% 
5 25.5% 25.7% 34.4% 14.4% 
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Supplementary Table S6: Statistics on number of reads supporting each variant  
Each observed variant is associated with a count: this gives the number of reads (either an 
assembled paired-end 2×75 bp or a single end read from an unassembled pair) that support 
the detection of that variant. Some variants are observed more frequently than others. This 
frequency reflects the inherent bias of Mu transposon insertion, amplification bias during 
transformations (where one variant may randomly grow to greater abundance than another), 
and stochastic fluctuations resulting from sequencing. This table summarizes the median 
count in the -3 bp and +3 bp libraries, as well as maximum and interquartile range. The 
distribution is shown in Supplementary Figure S7 as a histogram. 
Count wtPTE -3 bp wtPTE + 3bp 
Minimum observed 0 0 
Q1 4.9 11.0 
Median 22.0 47.2 
Q3 75.5 133.3 
Maximum 1420 3336 
Q3-Q1 70.6 122.3 
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Supplementary Table S7. Number of reads per distinct deletion observed by deep sequencing in wtPTE deletion libraries generated via TRIAD. 
The histograms relative to these distributions are plotted in Supplementary Figure S7. 
 
 
Number of distinct deletions 
  - 3 bp -6 bp -9 bp All deletions 
Total number of deletions 633 682 608 1923 
         
Number of reads per deletion 
        
1-4 reads 83 107 96 286 
5-9 reads 52 67 70 189 
10-39 reads 168 310 
(49%) 
212 369 
(54.1%) 
217 324 
(53.3%) 
597 1003 
(52,2%) 40-99 reads 142 157 107 406 
100-199 reads 86 82 64 232 
200-999 reads 93 102 
(16.1%) 
57 57 
(8.4%) 
53 64 
(8.9%) 
203 213 
(11.1%) ≥1000 reads 9 0 1 10 
                  
 
 
  
Supplementary Table S8. Fitness effects in TRIAD (insertion and deletion) and trinucleotide substitution libraries of wtPTE. 
 
  
Deletions Insertions Substitutions 
  
-3 bp -6 bp -9 bp All deletions +3 bp +6 bp +9 bp All insertions TriNEx 
 
Number of variants[a] 175 154 156 485 92 134 125 351 342 
P
A
R
A
O
X
O
N
A
S
E
 
Fitness effect[b]: 
         
Strongly deleterious 117 (66.9%) 143 (92.8%) 143 (91.7%) 403 (83.1%) 58 (63.2%) 106 (79.1%) 105 (84.0%) 269 (76.7%) 81 (23.8%) 
Mildly deleterious 41 (23.4%) 9 (5.9%) 11 (7.1%) 61 (12.6%) 14 (15.2%) 20 (14.9%) 13 (10.4%) 47 (13.4%) 100 (29.2%) 
Neutral 14 (8.0%) 2 (1.3%) 2 (1.3%) 18 (3.7%) 18 (19.5%) 7 (5.2%) 1 (0.8%) 26 (7.4%) 161 (47.0%) 
Beneficial 3 (1.7%) 0 (0.0%) 0 (0.0%) 3 (0.6%) 2 (2.2%) 1 (0.7%) 6 (4.8%) 9 (2.6%) 0 (0.0%) 
          
Average fitness change][d] 0.048 0.014 0.015 0.022 0.054 0.024 0.019 0.027 0.28 
 
[0.038 ; 0.062] [0.012 ; 0.016] [0.013 ; 0.017] [0.02 ; 0.025] [0.036 ; 0.082] [0.018 ; 0.031] [0.015 ; 0.025] [0.023 ; 0.033] [0.24 ; 0.33] 
Median fitness change[c] 0.03 <0.01 <0.01 <0.01 0.01 <0.01 <0.01 <0.01 0.63 
Minimum fitness change[c] <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
Maximum fitness change[c] 1.59 0.94 1.31 1.59 1.79 1.60 2.78 2.78 1.50 
          
A
R
IY
L
E
S
T
E
R
A
S
E
 (
4
-n
it
ro
p
h
e
n
y
l 
b
u
ty
ra
te
) Fitness effect[b]: 
         
Strongly deleterious 100 (57.2%) 137 (88.9%) 133 (85.2%) 370 (76.3%) 53 (57.7%) 99 (73.9%) 68 (54.3%) 220 (62.7%) 65 (19.1%) 
Mildly deleterious 40 (22.8%) 10 (6.5%) 9 (5.8%) 59 (12.2%) 16 (17.3%) 18 (13.4%) 42 (33.6%) 76 (21.6%) 96 (28.0%) 
Neutral 14 (8.0%) 6 (3.9%) 7 (4.5%) 27 (5.6%) 15 (16.3%) 8 (6.0%) 5 (4.0%) 28 (8.0%) 175 (51.1%) 
Beneficial 21 (12.0%) 1 (0.7%) 7 (4.5%) 29 (6.0%) 8 (8.7%) 9 (6.7%) 10 (8.0%) 27 (7.7%) 6 (1.8%) 
          
Average fitness change[c][d] 0.07 0.017 0.02 0.03 0.085 0.031 0.098 0.061 0.34 
 
[0.051 ; 0.095] [0.014 ; 0.02] [0.015 ; 0.026] [0.025 ; 0.035] [0.056 ; 0.13] [0.023 ; 0.043] [0.075 ; 0.13] [0.05; 0.074] [0.3 ; 0.4] 
Median fitness change[c] 0.03 <0.01 <0.01 <0.01 0.05 <0.01 0.09 0.04 0.70 
Minimum fitness change[c] <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
Maximum fitness change[c] 2.46 1.52 5.02 5.02 4.12 3.13 5.36 5.36 2.98 
          
 
[a] The number of variants sampled in each library was corrected to only take in-frame mutations into account. Overall, 178 variants from each TRIAD library (6 × 178 in total) and 435 trinucleotide 
substitution variants were randomly picked, expressed in E. coli and screened for hydrolysis of paraoxon and 4-nitrophenyl butyrate (see Table S9). The estimated number of frame-shifted variants 
(based on the frequencies in Table S1) was then subtracted from the numbers of highly deleterious variants (<0.01 in both activities). 
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[b] Mutations are classified as strongly deleterious (>10-fold activity decrease relative to wtPTE), mildly deleterious (10-fold—1.5-fold decrease), neutral (<1.5-fold change), and beneficial (>1.5-fold 
increase). 
[c] Changes in phosphotriesterase (native substrate: paraoxon) and esterase (promiscuous substrate: pNPB) activities are determined relative to those of wtPTE by comparing the initial rates in cell 
lysates measured under identical conditions with 200 µM of the respective substrates, resulting in a dimensionless ratio (see Methods).  
[d] The average fitness change refers to the change in initial rates as a consequence of mutation and is calculated as the geometric mean of the relative activities of the variants for each class of 
mutations (see Supplementary Table S9). The corresponding confidence intervals (5% risk of error) are indicated between brackets. 
  
Supplementary Table S9. Functional analysis of TRIAD and trinucleotide substitution 
libraries of wtPTE against paraoxon and 4-NPB 
Changes in paraoxonase (native substrate: paraoxon) and arylesterase (promiscuous substrate: 4-
nitrophenylbutyrate, 4-NPB) activities are determined relative to those of wtPTE by comparing the 
initial rates in cell lysates measured under identical conditions with 200 µM of the respective 
substrates (see Methods). Data are averages of triplicate values from three independent experiments 
and error values represent +/- 1 SEM. 
 
Due to its size, the table is located in the Source Data file.
  
Supplementary Table S10. Analysis of solvent-accessible surface area of mutated residues 
in wtPTE variants retaining ≥50% of the parental paraoxonase activity. 
The solvent accessible surface area (SASA) of residues mutated (either InDel or substitution) in 
wtPTE variants retaining ≥50% of the parental paraoxonase activity was calculated from the structure 
of wtPTE (PDB code: 4PCP) using the PISA web server at the European Bioinformatics Institute 
(http://www.ebi.ac.uk/pdbe/prot_int/pistart.html) 17. Relative accessible surface area (RSA) was 
defined as the ratio of the SASA for a given residue within the structured protein vs. in the free 
residue 18. Residues were classified as core for RSA < 0.25, and surface for RSA ≥ 0.25 19. 
 
Supplementary Table S10a. List of residues in wtPTE InDel variants retaining ≥50% of the 
parental paraoxonase activity. 
 
Residue no. SASA (Å2) RSA Location Corresponding variants 
34 79.4 0.93 surface F34aN34b 
35 88.8 0.59 surface ∆D35R36, P35a, F35a, K35aC35b, F35aH35b, 
S35aC35bP35c 
36 124.2 0.52 surface ∆R36, E36aY36bK36c 
37 4.5 0.02 core T37aI37b 
42 24.2 0.28 surface H42a 
43 77.6 0.54 surface P43H/A43a 
45 48.6 0.33 surface C45aP45b 
49 1.6 0.01 core ∆A49 
75 42.7 0.35 surface ∆S75R76K77 
155 96.2 0.51 surface ∆Q155 
161 48.7 0.33 surface T161K/P161a 
173 66.1 0.45 surface ∆T173 
174 8.0 0.09 core ∆G174 
203 34.7 0.31 surface ∆A203 
205 85.0 0.70 surface L205aG205b 
206 102.0 0.54 surface Q206H/∆R207G208 
259 10.4 0.09 core P259a 
261 56.0 0.66 surface S261a, P261a, G261aR261b, D261aT261bS261c 
262 41.6 0.23 core ∆L262, I262a, P262aT262bT262c 
263 126.4 0.69 surface ∆E263, E263V/Q263a 
266 97.8 0.87 surface ∆A266, G266aR266b 
267 31.8 0.26 surface A266G/∆S267 
269 50.3 0.41 surface ∆S269 
292 56.5 0.25 core ∆Y292 
293 45.9 0.22 core ∆M293, M293I/∆K294 
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Residue no. SASA (Å2) RSA Location Corresponding variants 
319 84.7 0.69 surface S319a 
337 109.0 0.45 surface ∆R337 
338 126.9 0.69 surface ∆E338 
339 91.4 0.43 surface Q339a, K339M/Q339a, V339a 
362 122.6 0.68 surface ∆L362, K362a 
363 178.5 0.74 surface K363aR363bR363c 
 
Supplementary Table S10b. List of residues in wtPTE substitution variants retaining ≥50% of 
the parental paraoxonase activity. 
 
Residue no. SASA (Å2) RSA Location Corresponding variants 
36 124.2 0.52 surface R36N 
44 18.0 0.10 core I44K/T45A, I44T/T45A 
45 48.6 0.33 surface I44K/T45A, I44T/T45A 
47 98.0 0.80 surface S47Y, S47C/E48Q 
48 96.6 0.53 surface S47C/E48Q 
49 1.6 0.01 core A49M 
54 9.0 0.06 core T54S 
63 41.2 0.36 surface A63T, A63S 
67 183.9 0.76 surface R67G, R67T, R67H 
73 29.3 0.13 core F73C 
75 42.7 0.35 surface S75G 
80 8.1 0.07 core A80G, A80G/E81K 
81 75.9 0.41 surface A80G/E81K 
89 124.0 0.51 surface R89F 
92 94.9 0.84 surface A92G/A93T 
93 27.5 0.24 core A93V 
96 85.8 0.36 surface R96T 
100 0.9 0.01 core D100A 
102 1.3 0.01 core S102G, S102T 
109 20.8 0.14 core D109C, D109S 
117 0.1 0.00 core T117N/P118A 
118 148.9 0.62 surface R118K, R118G, R118Q, T117N/P118A 
143 19.7 0.12 core V143A, V143A/E144K 
144 109.2 0.60 surface E144Q, E144I 
147 13.6 0.09 core T147S 
151 22.0 0.12 core L151R 
155 96.2 0.51 surface Q155L 
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Residue no. SASA (Å2) RSA Location Corresponding variants 
162 53.2 0.63 surface G162R, G162V 
198 0.0 0.00 core V198L 
206 102.0 0.54 surface Q206L, Q206H 
208 1.1 0.01 core G208A 
223 27.3 0.19 core P223A 
235 85.3 0.57 surface D235T 
238 84.0 0.69 surface S238G 
241 25.4 0.17 core T241I 
242 53.0 0.47 surface A242P 
262 41.6 0.23 core L262H, L262M, L262I 
263 126.4 0.69 surface E263Q 
266 97.8 0.87 surface A266D, A266G 
269 50.3 0.41 surface S269H, S269A 
282 77.9 0.43 surface L282S 
292 56.5 0.25 core Y292G, Y292R, Y292F, Y292L 
293 45.9 0.22 core M293T 
302 3.1 0.01 core W302F 
308 38.6 0.32 surface S308C 
311 94.8 0.65 surface T311A 
312 97.9 0.62 surface N312D 
323 26.4 0.18 core D323E/G324R 
324 10.1 0.12 core D323E/G324R 
330 75.1 0.42 surface L330S, L330I, L330A 
331 116.1 0.48 surface R331G 
334 56.3 0.39 surface P334N, P334T, P334A 
337 109.0 0.45 surface R337Y 
339 91.4 0.43 surface K339T, K339R 
342 75.3 0.53 surface P342L/Q343E, P342L, P342W, P342R 
343 98.0 0.52 surface Q343L, Q343G, P342L/Q343E, Q343A, Q343I, Q343W, 
Q343P, Q343E 
348 7.9 0.09 core G348A 
351 57.4 0.36 surface V351D 
356 102.8 0.43 surface R356E 
363 178.5 0.74 surface R363G 
 
  
Supplementary Table S11. Activity and solubility of InDel (-3 and +3 bp) and substitutions 
(TriNucleotide Exchange; TriNEx) variants of wtPTE phosphotriesterase. 
Upon transformation of the DNA libraries (-3 and +3 bp TRIAD libraries and TriNEx library) into E. coli 
BL21(DE3), a total of 192 colonies (64 for each library) were selected randomly, and their 
corresponding PTE variants sequenced to discard the ones with frameshifting mutations. Variants 
with non-frameshifting mutations were then screened for phosphotriesterase (PTE) activity and 
soluble expression (in the absence of GroEL/ES). Changes in PTE activity are determined relative to 
those of wtPTE by comparing the initial rates in cell lysates measured under identical conditions with 
200 µM of the native paraoxon substrate (see Methods). Data are averages of triplicate values from 
three independent experiments and error values represent +/- 1 SEM. Relative soluble expression 
levels are determined as the ratio in protein expression levels in the clear lysate (supernatant) 
between variants and the parent enzyme wtPTE measured by SDS-PAGE (See Methods). The data 
are also plotted in Supplementary Figure S11. 
Variant 
Relative PTE 
activity 
Relative soluble 
expression level 
Distance to active 
site metal (Å)[a] 
RSA[b] 
Location[b] 
(surface/core) 
-3 bp (TRIAD)       
ΔG261 0.11 ± 0.05 1.04 22.4 0.58 surface 
ΔS62 <0.001 1.12 13.2 0.23 core 
ΔL271 0.058 ± 0.006 1.44 11.5 0.28 surface 
ΔA114 <0.001 0.30 18.8 0.11 core 
ΔE144 <0.001 0.26 25.7 0.51 surface 
ΔP334 <0.001 0.31 23.6 0.37 surface 
ΔQ343 0.015 ± 0.006 0.30 27.2 0.46 surface 
ΔA286 0.021 ± 0.01 0.38 23.2 0.22 core 
ΔQ343 0.015 ± 0.011 0.32 27.2 0.46 surface 
ΔR225 0.0041 ± 0.0004 0.65 18.3 0.05 core 
ΔE181 <0.001 0.21 19.4 0.27 surface 
ΔV143 0.0061 ± 0.0015 0.21 23.4 0.12 core 
S258R/ΔA259 0.094 ± 0.059 1.20 14.8 0.06 core 
H257R/ΔS258 <0.001 0.98 11.1 0.04 core 
ΔA114 <0.001 0.10 18.8 0.11 core 
ΔD235 0.17 ± 0.07 0.84 19.7 0.46 surface 
ΔL346 0.0013 ± 0.0009 0.19 22.4 0.03 core 
ΔL330 0.4 ± 0.17 0.90 20.0 0.39 surface 
L136P/ΔS137 <0.001 0.76 22.0 0.56 surface 
ΔT52 <0.001 0.33 15.1 0.01 core 
ΔQ211 0.12 ± 0.04 0.36 19.6 0.27 surface 
ΔL262 0.23 ± 0.08 1.13 20.9 0.22 core 
A90V/ΔR91 <0.001 0.35 17.2 0.00 core 
ΔH55 <0.001 0.87 6.1 0.03 core 
ΔE115 <0.001 0.14 20.5 0.43 surface 
F73C/ΔG74 0.034 ± 0.014 0.96 18.6 0.13 core 
ΔV40 <0.001 0.23 18.2 0.02 core 
ΔA355 0.0013 ± 0.001 0.32 19.5 0.15 core 
ΔS102 <0.001 0.27 7.0 0.01 core 
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Variant 
Relative PTE 
activity 
Relative soluble 
expression level 
Distance to active 
site metal (Å)[a] 
RSA[b] 
Location[b] 
(surface/core) 
D133E/ΔP134 <0.001 0.68 13.0 0.41 surface 
+3 bp (TRIAD) 
   
L251a <0.001 0.94 10.9 0.03 core 
I69a <0.001 0.44 21.7 0.51 surface 
P114a <0.001 0.25 18.8 0.11 core 
E144V/K144a <0.001 0.29 25.7 0.51 surface 
M69a <0.001 0.38 21.7 0.51 surface 
W276a 0.011 ± 0.005 1.09 19.2 0.20 core 
F291a 0.049 ± 0.021 1.14 26.9 0.64 surface 
L252a 0.0035 ± 0.0028 0.19 11.5 0.00 core 
F322a 0.015 ± 0.005 0.85 17.8 0.67 surface 
T279a 0.0097 ± 0.0051 0.87 20.0 0.30 surface 
T350R/A350a <0.001 0.14 17.8 0.08 core 
V255a 0.012 ± 0.004 1.14 12.1 0.00 core 
S240a 0.039 ± 0.014 0.91 19.1 0.00 core 
S291a 0.21 ± 0.05 0.74 26.9 0.64 surface 
P256L/T256a 0.037 ± 0.015 1.27 12.4 0.03 core 
G69a 0.032 ± 0.014 1.08 21.7 0.51 surface 
V114a <0.001 0.20 18.8 0.11 core 
I284N/F284a 0.013 ± 0.003 0.74 18.7 0.00 core 
S260-Stop <0.001 0.17 19.9 0.51 surface 
R261a 0.4 ± 0.17 0.33 22.4 0.58 surface 
F188a <0.001 0.91 19.6 0.00 core 
L261a 0.5 ± 0.15 1.00 22.4 0.58 surface 
L251a <0.001 0.84 10.9 0.03 core 
V353a <0.001 0.20 19.0 0.00 core 
D271a 0.085 ± 0.052 1.07 11.5 0.28 surface 
C270a 0.13 ± 0.09 0.29 14.8 0.79 surface 
A63V/S63a <0.001 0.65 15.5 0.34 surface 
Substitutions (TriNEx) 
   
L262P 0.1 ± 0.04 0.83 20.9 0.22 core 
R118Q 0.62 ± 0.25 0.71 22.1 0.56 surface 
I250K 0.0017 ± 0.0007 0.25 14.4 0.00 core 
Y292D 0.7 ± 0.11 0.74 23.4 0.22 core 
I349K/T350S <0.001 0.22 19.2 0.02 core 
E115Q 0.63 ± 0.05 0.75 20.5 0.43 surface 
Y292S 0.63 ± 0.16 0.72 23.4 0.22 core 
H55A 0.32 ± 0.17 0.97 6.1 0.03 core 
E144G 0.44 ± 0.17 0.72 25.7 0.51 surface 
H55R <0.001 0.89 6.1 0.03 core 
S276C 0.55 ± 0.29 0.99 19.2 0.20 core 
G348F 0.37 ± 0.1 0.67 22.6 0.08 core 
R280K 0.46 ± 0.07 0.97 16.6 0.04 core 
G162A 0.21 ± 0.05 0.56 23.9 0.55 surface 
A165V/G166R 0.003 ± 0.0008 0.23 16.1 0.00 core 
G42V 0.075 ± 0.008 0.37 22.9 0.25 core 
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Variant 
Relative PTE 
activity 
Relative soluble 
expression level 
Distance to active 
site metal (Å)[a] 
RSA[b] 
Location[b] 
(surface/core) 
A80L 1.2 ± 0.26 1.03 18.6 0.07 core 
S62V 0.27 ± 0.06 1.08 13.2 0.23 core 
G209N 0.13 ± 0.01 0.71 15.7 0.00 core 
P70H/E71K <0.001 0.40 20.9 0.24 core 
G209L 0.067 ± 0.019 0.67 15.7 0.00 core 
R89L 0.69 ± 0.19 1.04 19.7 0.47 surface 
L262R 0.77 ± 0.1 0.94 20.9 0.22 core 
V143E/E144Q 0.19 ± 0.09 0.58 23.4 0.12 core 
P197R/V198L 0.0033 ± 0.0007 0.30 15.9 0.00 core 
M314K/D315H 0.0045 ± 0.002 1.06 14.1 0.11 core 
E159D 0.75 ± 0.06 1.20 21.5 0.42 surface 
R36A 0.52 ± 0.04 0.97 24.1 0.47 surface 
L262G 0.21 ± 0.03 1.11 20.9 0.22 core 
S299R <0.001 0.96 9.6 0.00 core 
 
[a] Pairwise distances between the active site metals and all the mutated residues (alpha carbons) were calculated from the 
structure of wtPTE (PDB 4PCP) using a python script in PyMol (https://pymolwiki.org/index.php/Pairwise_distances). 
[b] RSA: Relative solvent accessibility (see Supplementary Table S10). Residues were classified as core for RSA < 0.25, and 
surface for RSA ≥ 0.25. 
 
  
Supplementary Table S12. Effects of InDels (-3 and +3 bp) and substitutions (TriNucleotide 
Exchange; TriNEx) on activity and soluble expression of wtPTE phosphotriesterase. 
 
  Deletions (-3 bp) Insertions (+3 bp) 
Substitutions 
(TriNEx) 
Number of variants screened [a] 30 27 30 
Fitness (activity) effects [b] 
   
Beneficial 0 0 0 
Neutral 0 0 5 
Mildly deleterious 5 4 15 
Deleterious 25 23 10 
Average fitness change [c] 0.005 0.008 0.08 
Minimum fitness change [b] [c] < 0.001 < 0.001 < 0.001 
Maximum fitness change [b] [c] 0.4 0.5 1.2 
Effects on soluble expression [d]       
Neutral 11 13 14 
Mildly destabilizing 2 3 10 
Strongly destabilizing 17 11 6 
Average solubility change [e] 0.45 0.54 0.68 
Solubility-neutral mutations 
(Variants with ≤ 25% decrease in soluble expression) 
Number of variants 11 13 14 
Average distance of mutation to active site 
metal (Å) [f] 
16.4 ± 5.1 17.3 ± 5 16.5 ± 5.6 
Median distance to active site metal 18.6 19.1 18.9 
Minimum distance to active site metal 6.1 10.9 6.1 
Maximum distance to active site metal 22.4 26.9 24.1 
Core residues 6 7 11 
Surface residues 5 6 3 
Solubility-neutral and functionally deleterious mutations 
(Variants with ≤ 25% decrease in soluble expression and ≥ 10-fold decrease in PTE activity) 
Number of variants 7 12 3 
Average distance of mutation to active site 
metal (Å) [f] 
13.9 ± 4.8 16.8 ± 5 9.9 ± 3.3 
T-test (p-value) [f] 0.17 0.42 0.04 
Median distance to active site metal  13.9 18.4 9.6 
Minimum distance to active site metal  6.1 10.9 6.1 
Maximum distance to active site metal  22.0 26.9 14.1 
Core residues 5 7 3 
Surface residues 2 5 0 
 
[a] See Supplementary Table S11 for screening conditions and results. 
[b] Mutational effects on enzyme fitness relate to changes in phosphotriesterase (native substrate: paraoxon) activities, which 
are determined relative to those of wtPTE by comparing the initial rates in cell lysates measured under identical conditions with 
200 µM of the respective substrates, resulting in a dimensionless ratio (see Methods). Mutations are classified as strongly 
deleterious (>10-fold activity decrease, relative to wtPTE), mildly deleterious (10-fold to 1.5-fold decrease), neutral (<1.5-fold 
change), and beneficial (>1.5-fold increase). 
[c] The average fitness change refers to the change in initial rates as a consequence of mutation and is calculated as the 
geometric mean of the relative activities of the variants for each type of mutation (see Supplementary Table S11). 
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[d] Mutational effects on kinetic stability were inferred by the levels of soluble expression for each variant relative to that of the 
parent enzyme wtPTE. Mutations are classified as strongly destabilizing (more than 50% decrease in soluble expression, 
relative to wtPTE), mildly destabilizing (50% to 25% decrease in soluble expression), and neutral (less than 25% decrease in 
soluble expression). 
[e] The average solubility change is calculated as the geometric mean of the relative solubility changes of the variants for each 
type of mutation (see Supplementary Table S11). 
[f] For these variants (see Supplementary Table S11), the average distance of mutations to the active site metals is given as 
mean ± standard deviation. A T-test was performed to evaluate if the distribution of these distances are significantly different 
between solubility-neutral mutations (variants with ≤ 25% decrease in soluble expression) and solubility-neutral but functionally-
deleterious mutations (variants with ≤ 25% decrease in soluble expression and ≥ 10-fold decrease in PTE activity). 
 
 
 
 
  
Supplementary Table S13. Cell lysate activity levels of InDel variants of wtPTE improved in arylesterase activity.  
Changes in phosphotriesterase (PTE; native substrate: paraoxon) and arylesterase (AE; promiscuous substrates: 4-NPB or 2-NH) activities are determined 
relative to those of wtPTE by comparing the initial rates in cell lysates measured under identical conditions with 200 µM of the respective substrates (see 
Methods). Activities were recorded after expression of wtPTE variants in the presence (+GroEL/ES) or absence (-GroEL/ES) of chaperone over-expression. 
Data are averages of triplicate values from three biological replicates and error values represent +/- 1 SEM. Part of this data is shown on Figures 6A and 6B 
which consist of AE vs. PTE activity plots in the presence of GroEL/ES chaperone.  
Supplementary Table S13A: Promiscuous activity against 4-NPB. 
    Activity relative to wtPTE   
   AE (4-NPB) PTE (Paraoxon) Relative chaperone 
dependency [c] Library Protein mutation [a] + GroEL/ES - GroEL/ES + GroEL/ES - GroEL/ES 
-3 bp ΔQ206 2.3 ± 0.3 2.1 ± 0.1 0.68 ± 0.15 0.58 ± 0.04 1.1 
 
∆D232 2.2 ± 0.1 2.3 ± 0.1 0.06 ± 0.01 0.05 ± 0.01 0.9 
 
∆T234 2.3 ± 0.2 1.9 ± 0.2 0.41 ± 0.03 0.33 ± 0.05 1.2 
 
ΔH254 2.4 ± 0.2 2.3 ± 0.1 < 0.01 <0.01 1.0 
 
∆S269 2.0 ± 0.1 2.0 ± 0.1 0.86 ± 0.04 0.97 ± 0.06 1.0 
  L272R/∆G273 2.2 ± 0.2 2.5 ± 0.2 0.22 ± 0.08 0.27 ± 0.12 0.9 
-6 bp ΔH257S258 5.2 ± 0.8 4.4 ± 0.3 0.06 ± 0.01 0.05 ± 0.01 1.2 
 
∆S258A259 2.2 ± 0.3 1.5 ± 0.1 0.07 ± 0.02 0.06 ± 0.01 1.4 
 
∆L262E263/D264H 2.1 ± 0.7 1.3 ± 0.7 0.10 ± 0.04 0.08 ± 0.02 1.7 
 
∆S267A268 or ∆S269A270 2.3 ± 0.1 1.0 ± 0.2 0.25 ± 0.03 0.16 ± 0.03 2.4 
 
ΔA270L271 2.2 ± 0.2 1.6 ± 0.2 0.18 ± 0.02 0.16 ± 0.07 1.4 
 
ΔL271L272 3.0 ± 0.3 2.3 ± 0.2 0.16 ± 0.03 0.13 ± 0.02 1.3 
  ΔG273I274 3.2 ± 0.3 2.3 ± 0.2 0.12 ± 0.02 0.08 ± 0.01 1.4 
-9 bp ∆G261L262E263 [b] 4.6 ± 0.6 4.0 ± 0.2 0.10 ± 0.05 0.13 ± 0.02 1.1 
 
∆A268S269A270 2.6 ± 0.1 2.6 ± 0.1 0.09 ± 0.01 0.09 ± 0.01 1.0 
  ∆L272G273I274 2.4 ± 0.2 2.7 ± 0.2 0.24 ± 0.02 0.28 ± 0.03 0.9 
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+3 bp Y255a 2.3 ± 0.4 2.3 ± 0.3 < 0.01 <0.01 1.0 
 
L256a 14.4 ± 1.3 16.6 ± 1.2 < 0.01 <0.01 0.9 
 
H257a 2.9 ± 0.3 3.7 ± 0.1 0.17 ± 0.02 0.13 ± 0.01 0.8 
 
D258a/A259T 3.6 ± 0.7 4.4 ± 0.2 0.34 ± 0.06 0.29 ± 0.03 0.8 
 
V258a/A259P 3.7 ± 0.1 3.1 ± 0.5 0.79 ± 0.26 0.70 ± 0.04 1.2 
 
I258a 2.8 ± 0.8 2.3 ± 0.3 0.49 ± 0.13 0.41 ± 0.06 1.2 
 
P259a 3.4 ± 0.2 3.9 ± 0.3 0.95 ± 0.06 1.12 ± 0.09 0.9 
 
A259G/S259a 4.1 ± 0.2 3.8 ± 0.2 0.37 ± 0.03 0.30 ± 0.04 1.1 
 
S261a 2.1 ± 0.2 1.8 ± 0.2 0.78 ± 0.01 0.76 ± 0.02 1.2 
 
P261a 2.7 ± 0.1 2.7 ± 0.1 0.95 ± 0.01 0.94 ± 0.01 1.0 
 
W261a 3.1 ± 0.4 1.0 ± 0.2 0.11 ± 0.02 0.05 ± 0.01 3.1 
  S319a 2.5 ± 0.1 2.6 ± 0.1 1.24 ± 0.03 1.30 ± 0.04 1.0 
+6 bp G255aA255b 9.4 ± 0.9 8.1 ± 0.5 0.05 ± 0.01 0.03 ± 0.01 1.2 
 
D258aR258b/A259S 4.0 ± 0.1 3.2 ± 0.2 0.21 ± 0.01 0.16 ± 0.02 1.2 
 
P261aC261b 2.6 ± 0.1 2.6 ± 0.1 0.21 ± 0.01 0.22 ± 0.01 1.0 
 
I261aG261b 3.3 ± 0.1 1.9 ± 0.1 1.39 ± 0.11 0.64 ± 0.04 1.7 
 
E261aS261b 4.0 ± 0.2 2.8 ± 0.2 0.70 ± 0.05 0.41 ± 0.03 1.4 
 
V262aL262b 4.8 ± 0.2 1.9 ± 0.1 1.25 ± 0.03 0.48 ± 0.02 2.5 
 
W262aK262b 4.3 ± 0.1 2.9 ± 0.2 0.46 ± 0.04 0.26 ± 0.04 1.5 
 
L265aP265b 2.8 ± 0.2 1.9 ± 0.1 1.03 ± 0.06 0.62 ± 0.05 1.4 
 
G265aY265b/A266S 2.9 ± 0.1 2.1 ± 0.2 1.24 ± 0.07 0.70 ± 0.05 1.4 
 
G266aR266b 2.6 ± 0.1 2.4 ± 0.1 0.79 ± 0.10 0.50 ± 0.15 1.1 
 
Y268aR268b 2.9 ± 0.2 2.5 ± 0.3 0.16 ± 0.01 0.14 ± 0.01 1.2 
 
Q271aR271b 3.0 ± 0.2 3.4 ± 0.2 0.13 ± 0.02 0.16 ± 0.02 0.9 
 
R271aC271b 2.8 ± 0.1 1.9 ± 0.4 0.12 ± 0.01 0.05 ± 0.01 1.4 
  Y275aG275b 3.1 ± 0.2 2.7 ± 0.3 0.09 ± 0.01 0.07 ± 0.01 1.2 
+9 bp T121aS121bD121c 2.8 ± 0.7 1.2 ± 0.1 0.21 ± 0.06 0.06 ± 0.01 2.3 
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K257aH257bG257c 4.5 ± 0.3 5.3 ± 0.4 0.17 ± 0.02 0.21 ± 0.03 0.9 
 
S258aG258bF258c 2.3 ± 0.3 2.0 ± 0.2 0.25 ± 0.02 0.18 ± 0.02 1.2 
 
C261aK261bL261c 5.4 ± 0.3 6.2 ± 0.5 0.22 ± 0.01 0.23 ± 0.01 0.9 
 
D261aT261bS261c 3.3 ± 0.1 3.7 ± 1.1 1.18 ± 0.10 1.48 ± 0.15 0.9 
 
D261aW261bK261c 2.9 ± 0.1 2.7 ± 0.3 0.43 ± 0.01 0.44 ± 0.01 1.1 
 
H261aI261bL261c 4.9 ± 0.2 2.3 ± 0.7 0.22 ± 0.01 0.08 ± 0.01 2.1 
 
V261aN261bG261c 2.6 ± 0.1 1.2 ± 0.1 0.18 ± 0.01 0.09 ± 0.01 2.1 
 
G262aL262bE262c/E263K 2.3 ± 0.4 2.5 ± 0.2 1.00 ± 0.15 0.95 ± 0.13 0.9 
 
L268aG268bC268c/S269P 2.1 ± 0.1 1.4 ± 0.1 0.13 ± 0.01 0.05 ± 0.01 1.6 
 
S269aG269bS269c 3.0 ± 0.1 2.8 ± 0.1 0.41 ± 0.05 0.38 ± 0.02 1.1 
 
T269aS269bG269c 2.5 ± 0.2 2.0 ± 0.4 0.35 ± 0.04 0.25 ± 0.05 1.3 
 
E276aG276bM276c 2.7 ± 0.3 2.5 ± 0.1 0.12 ± 0.02 0.10 ± 0.02 1.0 
  A309aA309bA309c 2.1 ± 0.1 1.8 ± 0.2 0.28 ± 0.02 0.24 ± 0.02 1.1 
 
Supplementary Table S13B: Promiscuous activity against 2-NH. 
    Activity relative to wtPTE   
   AE (2-NH) PTE (Paraoxon) Relative chaperone 
dependency[c] Library Protein mutation [a] + GroEL/ES - GroEL/ES + GroEL/ES - GroEL/ES 
-3 bp ∆G273 3.1 ± 0.3 2.2 ± 0.3 0.20 ± 0.01 0.15 ± 0.02 1.4 
 
∆L303 3.3 ± 0.5 5.6 ± 0.2 < 0.01 < 0.01 0.6 
 
∆S308 8.7 ± 1.2 2.8 ± 0.1 0.41 ± 0.04 0.15 ± 0.01 3.1 
 
∆T311 6.3 ± 0.6 3.2 ± 0.3 0.48 ± 0.04 0.31 ± 0.02 1.9 
 
∆V316 4.1 ± 0.6 3.9 ± 0.2 0.04 ± 0.01 < 0.01 1.1 
  ∆M317 9.5 ± 0.7 5.3 ± 0.6 < 0.01 < 0.01 1.8 
-6 bp ∆I260G261 2.6 ± 0.1 1.7 ± 0.1 0.02 ± 0.01 < 0.01 1.5 
(Table S13 continued) 
 SI-75  
 
I313N/∆M314D315 5.2 ± 0.2 4.4 ± 0.2 < 0.01 < 0.01 1.2 
-9 bp ∆P256H257S258 8.7 ± 0.5 4.9 ± 0.3 < 0.01 < 0.01 1.8 
 
∆G261L262E263 [b] 3.6 ± 0.3 1.6 ± 0.1 0.29 ± 0.01 0.23 ± 0.01 2.3 
  ∆A270L271L272G273 10.5 ± 2.0 2.6 ± 0.2 0.58 ± 0.08 0.22 ± 0.03 4.1 
+3 bp A310a 8.1 ± 0.2 5.1 ± 0.3 0.93 ± 0.06 0.79 ± 0.05 1.6 
 
G311a 15.7 ± 3.2 14.4 ± 3.6 0.28 ± 0.04 0.36 ± 0.10 1.1 
 
P311a 5.7 ± 0.3 4.6 ± 0.1 0.24 ± 0.02 0.21 ± 0.02 1.2 
 
I313R/F313a 14.3 ± 0.5 9.7 ± 0.6 0.11 ± 0.03 0.03 ± 0.01 1.5 
 
I313M/F313a 5.0 ± 0.3 3.7 ± 0.3 < 0.01 < 0.01 1.4 
+6 bp V99G/Q99aI99b 6.5 ± 0.6 5.0 ± 0.4 0.46 ± 0.04 0.30 ± 0.03 1.3 
 
P256R/G256aA256b 138.6 ± 11.4 102.9 ± 4.7 < 0.01 < 0.01 1.3 
 
S256aG256b 28.0 ± 1.3 29.6 ± 2.3 < 0.01 < 0.01 0.9 
 
V256aW256b 9.0 ± 1.8 8.8 ± 1.1 0.07 ± 0.02 0.03 ± 0.01 1.0 
 
H257Q/T257aY257b 4.9 ± 1.0 2.1 ± 0.2 1.52 ± 0.18 0.85 ± 0.08 2.4 
 
I313K/V313aV313b 10.6 ± 1.4 12.9 ± 2.1 0.04 ± 0.01 0.12 ± 0.08 0.8 
 
I313S/S313aL313b 10.0 ± 1.1 7.4 ± 0.6 0.02 ± 0.01 0.02 ± 0.01 1.3 
+9 bp V310A/S310aD310bI310c 5.2 ± 0.6 8.1 ± 0.4 0.31 ± 0.03 0.37 ± 0.02 0.6 
 
T311K/P311aE311bA311c 3.9 ± 0.1 0.6 ± 0.1 < 0.01 < 0.01 6.6 
  T311S/M311aV311bS311c 3.0 ± 0.2 1.9 ± 0.3 0.36 ± 0.03 0.16 ± 0.05 1.6 
 
[a] The symbol ∆ before a residue (or a group of residues) signifies that this (or these) residue(s) have been  deleted. Inserted residues are labelled using the 
number of the position after which they are inserted and alphabetical order (e.g., glutamine and tyrosine residues inserted in this order after the residues at 
position 230 would be labelled Q230aY230b). 
[b] This variant (∆G261L262E263) was found in both screening campaign against 4-NPB and 2-NH. 
[c] Relative chaperone dependency refers to the ratio of relative AE activities in the presence vs. absence of chaperone over-expression. 
  
Supplementary Table S14. Change in soluble expression of PTE InDel variants improved in 
arylesterase activity in the presence or absence of chaperone co-expression. 
The soluble expression of each PTE variant was analyzed by SDS-PAGE (shown in Supplementary 
Figure S14). PTE appears as a minor and major band in the insoluble fraction, and the major band 
only in the soluble fraction. The intensity of both bands combined was quantified using ImageJ and 
normalized to background intensity. The percentage of soluble expression is given by: soluble band 
intensity / (soluble band intensity + pellet band intensity). 
Soluble expression Without GroEL/ES With GroEL/ES 
wtPTE 63% 77% 
∆A270L271L272G273 90% 81% 
P256R/G256aA256b 56% 59% 
S256aG256b 59% 70% 
G311a 64% 83% 
 
 
  
Supplementary Table S15. Sequence analysis of naïve TRIAD libraries focused on Loop 7 of 
wtPTE. 
Sequences were determined from randomly chosen variants upon generation of the libraries. 
Residues are numbered according to the crystal structure of wtPTE (PDB: 4PCP). Occurrence refers 
to the number of times that a specific mutation was observed among the sequenced variants. 
Library 
 
Variant 
number 
DNA mutation 
Length 
change (bp) 
Protein mutation Occurrence 
-3 bp 1 GGT(CTAG)AAG -4 bp frameshift n.a. 
 
2 C(TGG)GT -3 bp L272R/∆G273 8 
 
3 AG(TGCG)A -4 bp frameshift n.a. 
 
4 TC(AGC)C -3 bp ∆A270 7 
 
5 CT(GGGT)A -4 bp frameshift n.a. 
 
6 GA(CCA)T -3 bp ∆H254 3 
 
7 C(TGG)GT -3 bp L272R/∆G273 8 
 
8 GG(TCT)A -3 bp ∆L262 9 
 
9 ATT(CCG)CAC -3 bp ∆P256 4 
 
10 CT(AGA)C -3 bp ∆D253 2 
 
11 GA(CCA)T -3 bp ∆H254 3 
 
12 ATT(CCG)CAC -3 bp ∆P256 4 
 
13 A(TTG)GT -3 bp I260S/∆G261 2 
 
14 C(TGG)GT -3 bp L272R/∆G273 8 
 
15 CGT(TCG)TGG -3 bp ∆S276 3 
 
16 C(TGG)GT -3 bp L272R/∆G273 8 
 
17 A(TTG)GT -3 bp I260S/∆G261 2 
 
18 TC(AGC)C -3 bp ∆A270 7 
 
19 TC(AGC)C -3 bp ∆A270 7 
 
20 GGT(CTA)GAA -3 bp ∆L262 9 
 
21 ATT(GGT)CTA -3 bp ∆G261 1 
 
22 CT(CCT)G -3 bp ∆L271/272 1 
 
23 GGT(CTA)GAA -3 bp ∆L262 9 
 
24 CAC(AGT)GCG -3 bp ∆S258 2 
 
25 GG(TCT)A -3 bp ∆L262 9 
 
26 TCG(TGG)CAA -3 bp ∆W277 2 
 
27 TCA(GCC)CTC -3 bp ∆A270 7 
 
28 TC(AGC)C -3 bp ∆A270 7 
 
29 CTA(GAA)GAT -3 bp ∆E263 2 
 
30 CAC(AGT)GCG -3 bp ∆S258 2 
 
31 GCA(TCAG)CCC -4 bp frameshift n.a. 
 
32 ATT(CCG)CAC -3 bp ∆P256 4 
 
33 C(TGG)GT -3 bp L272R/∆G273 8 
 
34 CTA(GAA)GAT -3 bp ∆E263 2 
 
35 T(CGT)GG -3 bp ∆S276 3 
 
36 G(GTA)TT -3 bp G273V/∆I274 1 
 
37 TC(AGC)C -3 bp ∆A270 7 
 
38 C(TGG)GT -3 bp L272R/∆G273 8 
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Library 
 
Variant 
number 
DNA mutation 
Length 
change (bp) 
Protein mutation Occurrence 
 
39 TCG(TGG)CAA -3 bp ∆W277 2 
 
40 AG(TGCG)A -4 bp Frameshift n.a. 
 
41 C(TAG)AA -3 bp L262Q/∆E263 2 
 
42 CGT(TCG)TGG -3 bp ∆S276 3 
 
43 CTA(GAC)CAT -3 bp ∆D253 2 
 
44 AT(TCCG)C -4 bp frameshift n.a. 
 
45 GG(TCT)A -3 bp ∆L262 9 
 
46 C(TAG)AA -3 bp L262Q/∆E263 2 
 
47 TCA(GCC)CTC -3 bp ∆A270 7 
 
48 C(TGG)GT -3 bp L272R/∆G273 8 
 
49 GG(TCT)A -3 bp ∆L262 9 
 
50 GGT(CTAG)AAG -4 bp frameshift n.a. 
 
51 GG(TCT)A -3 bp ∆L262 9 
 
52 AAT(GCG)AGT -3 bp ∆A266 1 
 
53 C(TGG)GT -3 bp L272R/∆G273 8 
 
54 GG(TCT)A -3 bp ∆L262 9 
 
55 ATT(CCG)CAC -3 bp ∆P256 4 
 
56 GA(CCA)T -3 bp ∆H254 3 
 
57 AG(TGCG)A -4 bp frameshift n.a. 
 
58 GG(TCT)A -3 bp ∆L262 9 
 
59 GCC(CTCC)TGG -4 bp frameshift n.a. 
-6 bp 1 CTC(CTGGGT)ATT -6 bp ∆L272G273 2 
 
2 GC(GAGTGC)ATCA -6 bp ∆S267A268 4 
 
3 ATC(GGTCTA)GAC -6 bp ∆G251L252 2 
 
4 G(GTCTAG)AA -6 bp ∆G261L262 5 
 
5 CT(CCTGGGT)ATTC -7 bp frameshift n.a. 
 
6 ATC(GGTCTAGA)CCA -8 bp frameshift n.a. 
 
7 GG(TCTAGA)AGAT -6 bp ∆L262E263 8 
 
8 T(CGTGGC)AA -6 bp S276stop 1 
 
9 ATT(CGTTCG)TGG -6 bp ∆R275S276 1 
 
10 AT(TGGTCT)A -6 bp ∆G261L262 5 
 
11 GG(TCTAGA)A -6 bp ∆L262E263 8 
 
12 AT(TGGTCTAG)A -8 bp frameshift n.a. 
 
13 AT(TGGTCT)A -6 bp ∆G261L262 5 
 
14 GC(GAGTGC)A -6 bp ∆S267A268 4 
 
15 CGT(TCGTGG)CAA -6 bp ∆S276W277 4 
 
16 CTC(CTGGGTA)TTC -7 bp frameshift n.a. 
 
17 GGT(CTAGAA)GAT -6 bp ∆L262E263 8 
 
18 CT(GGGTAT)T -6 bp ∆G273I274 3 
 
19 GG(TCTAGA)A -6 bp ∆L262E263 8 
 
20 C(TAGAAG)AT -6 bp L262H/∆E263D264 6 
 
21 C(TCCTGG)GT -6 bp L271R/∆L272G273 1 
 
22 CT(GGGTAT)T -6 bp ∆G273I274 3 
 
23 GG(TCTAGA)A -6 bp ∆L262E263 8 
 
24 GG(TCTAGA)A -6 bp ∆L262E263 8 
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Library 
 
Variant 
number 
DNA mutation 
Length 
change (bp) 
Protein mutation Occurrence 
 
25 ATT(CCGCAC)AGT -6 bp ∆P256H257 7 
 
26 AT(CGGTCTA)G -7 bp frameshift n.a. 
 
27 AT(TGGTCT)A -6 bp ∆G261L262 5 
 
28 C(TAGAAG)AT -6 bp L262H/∆E263D264 6 
 
29 TCG(TGGCAA)ACA -6 bp ∆W276Q277 1 
 
30 C(TAGAAG)AT -6 bp L262H/∆E263D264 6 
 
31 CTC(ATCGGTC)TAG -7 bp frameshift n.a. 
 
32 C(ACAGTG)CG -6 bp H257P/∆S258A259 2 
 
33 AT(TGGTCT)A -6 bp ∆G261L262 5 
 
34 CTC(CTGGGTA)TTC -7 bp frameshift n.a. 
 
35 AT(TCCGCA)C -6 bp ∆P256H257 7 
 
36 CTC(CTGGGT)ATT -6 bp ∆L272G273 2 
 
37 ATT(CCGCAC)AGT -6 bp ∆P256H257 7 
 
38 ATT(GGTCTAGA)AG -7 bp frameshift n.a. 
 
39 T(CAGCCC)TC -6 bp S269F/∆A270L271 2 
 
40 C(ACAGTG)CG -6 bp H257P/∆S258A259 2 
 
41 GG(TCTAGA)A -6 bp ∆L262E263 8 
 
42 CGT(TCGTGGC)AAA -7 bp frameshift n.a. 
 
43 CC(GCACAG)T -6 bp ∆H257S258 1 
 
44 CGT(TCGTGG)CAA -6 bp ∆S276W277 4 
 
45 GC(GAGTGC)A -6 bp ∆S267A268 4 
 
46 TC(AGCCCTC)C -7 bp frameshift n.a. 
 
47 GGT(CTAGAA)GAT -6 bp ∆L262E263 8 
 
48 GG(TCTAGA)A -6 bp ∆L262E264 1 
 
49 CTA(GACCATA)TTC -7 bp frameshift n.a. 
 
50 AT(TCCGCA)C -6 bp ∆P256H257 7 
 
51 CGT(TCGTGG)CAA -6 bp ∆S276W277 4 
 
52 GCC(CTCCTG)GGT -6 bp ∆L271L272 2 
 
53 ATT(CCGCAC)AGT -6 bp ∆P256H257 7 
 
54 C(TAGAAG)AT -6 bp L262H/∆E263D264 6 
 
55 ATT(CCGCAC)AGT -6 bp ∆P256H257 7 
 
56 CAT(ATTCCG)CAC -6 bp ∆I255P256 3 
 
57 CT(AGACCA)T -6 bp ∆D253H254 2 
 
58 CAT(ATTCCG)CAC -6 bp ∆I255P256 3 
 
59 C(TAGAAG)AT -6 bp L262H/∆E263D264 6 
 
60 ATT(CCGCAC)AGT -6 bp ∆P256H257 7 
 
61 C(TAGAAG)AT -6 bp L262H/∆E263D264 6 
 
62 GC(CCTCCT)G -6 bp ∆L271L272 2 
 
63 AA(TGCGAGT)G -7 bp frameshift n.a. 
 
64 CTA(GACCAT)ATT -6 bp ∆D253H254 2 
 
65 GC(GAGTGC)A -6 bp ∆S267A268 4 
 
66 CTC(CTGGGTA)TTC -7 bp frameshift n.a. 
 
67 C(ACAGTGC)GA -7 bp frameshift n.a. 
 
68 T(CAGCCC)TC -6 bp S269F/∆A270L271 2 
 
69 CT(GGGTAT)T -6 bp ∆G273I274 3 
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Library 
 
Variant 
number 
DNA mutation 
Length 
change (bp) 
Protein mutation Occurrence 
 
70 G(ACCATA)TT -6 bp D253V/∆H254I255 1 
 
71 GC(ATCAGC)C -6 bp ∆S269A270 1 
 
72 CAT(ATTCCG)CAC -6 bp ∆I255P256 3 
 
73 CGT(TCGTGG)CAA -6 bp ∆S276W277 4 
 
74 AT(CGGTCT)A -6 bp ∆G251L252 2 
 
75 G(CCCTCC)TG -6 bp A270V/∆L271L272 1 
 
76 GGT(CTAGACC)ATA -7 bp frameshift n.a. 
 
77 TC(AGCCCT)C -6 bp ∆A270L271 1 
+3 bp 1 GGT+A+CT +1 bp frameshift n.a. 
 
2 CA+AAA+T +3 bp H254Q/N254a 1 
 
3 C+GGT+TA +3 bp R261a 1 
 
4 GGT+TTT+CTA +3 bp F251a 1 
 
5 C+ATT+TG +3 bp H271a 2 
 
6 G+GCT+AA +3 bp E263G/Stop 1 
 
7 CTC+AT+C +2 bp frameshift n.a. 
 
8 CA+CCA+A +3 bp H277a 1 
 
9 CTA+CTA+GAA +3 bp L262a 4 
 
10 C+GGC+AC +3 bp R256a 1 
 
11 ATT+ATG+CCG +3 bp M255a 1 
 
12 T+TG+CGT +2 bp frameshift n.a. 
 
13 GA+GCT+C +3 bp D253E/L253a 1 
 
14 CT+TGT+A +3 bp V262a 1 
 
15 GGT+GTT+CTA +3 bp V261a 1 
 
16 GA+GA+CC +2 bp frameshift n.a. 
 
17 GGTC+A+TAGA +1 bp frameshift n.a. 
 
18 GA+ATA+CCAT +3 bp D253E/Y253a 1 
 
19 G+AT+CGA +2 bp frameshift n.a. 
 
20 ATT+AGT+GGT +3 bp S260a 1 
 
21 GG+GTC+T +3 bp S261a 1 
 
22 CT+GTG+C +3 bp C271a 1 
 
23 GGT+TA+CTAG +2 bp frameshift n.a. 
 
24 G+AGG+CG +3 bp E265a 1 
 
25 CTA+T+GA +1 bp frameshift n.a. 
 
26 AT+GAT+T +3 bp M259a 1 
 
27 C+TA+CGC +2 bp frameshift n.a. 
 
28 CTC+CAT+CTG +3 bp H271a 2 
 
29 GGT+TG+CTAG +2 bp frameshift n.a. 
 
30 CT+CTT+C +3 bp F271a 3 
 
31 ATT+TCC+CCG +3 bp S255a 1 
 
32 C+ATC+TA +3 bp H261a 1 
 
33 CT+CTT+G +3 bp L272a 1 
 
34 CT/A+G+AGA +1 bp frameshift n.a. 
 
35 T+GTT+CA +3 bp C268a 1 
 
36 GGT+TAG+CTA +3 bp Stop 2 
 
37 CCGC+CGC+AC +3 bp P256a 1 
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Library 
 
Variant 
number 
DNA mutation 
Length 
change (bp) 
Protein mutation Occurrence 
 
38 AA+AG+TG +2 bp frameshift n.a. 
 
39 CGTT+GAT+CG +3 bp Stop 2 
 
40 CTC+TTT+CTG +3 bp F271a 3 
 
41 CGT+A+TC +1 bp frameshift n.a. 
 
42 CT+TCT+A +3 bp L262a 4 
 
43 C+GT+CGC +2 bp frameshift n.a. 
 
44 CTA+TCA+GAC +3 bp S252a 1 
 
45 C+AGT+TG +3 bp Q271a 1 
 
46 GG+CAT+T +3 bp I261a 1 
 
47 TCA+TCA+GCC +3 bp S269a 1 
 
48 ATC+AT+GGTC +2 bp frameshift n.a. 
 
49 CT+TCT+A +3 bp L262a 4 
 
50 GT+AC+CTAG +2 bp frameshift n.a. 
 
51 GGT+GAA+CTA +3 bp E261a 1 
 
52 A+ATA+CA +3 bp N278a 1 
 
53 ATT+CTT+CCG +3 bp L255A 1 
 
54 CT+TAG+G +3 bp R272a 1 
 
55 GGT+GCT+CTA +3 bp A261a 2 
 
56 GGT+A+CT +1 bp frameshift n.a. 
 
57 CC+C+GCA +1 bp frameshift n.a. 
 
58 CT+CG+AG +2 bp frameshift n.a. 
 
59 CT+TGT+A +3 bp V252a 1 
 
60 ATT+ATT+CCG +3 bp I255a 1 
 
61 CT+TCA+A +3 bp Q262a 1 
 
62 CT+TC+GG +2 bp frameshift n.a. 
 
63 CT+TTT+A +3 bp L262a 4 
 
64 C+CTC+TA +3 bp P251a 1 
 
65 GAC+TC+C +2 bp frameshift n.a. 
 
66 GGT+GG+CTAG +2 bp frameshift n.a. 
 
67 GGTC+CAT+TA +3 bp P261a 2 
 
68 GCGA+CGA+TT +3 bp T259a 1 
 
69 CTC+TTT+CTG +3 bp F271a 3 
 
70 CCG+TC+C +2 bp frameshift n.a. 
 
71 GCGAT+GAG+T +3 bp I260M/S260a 1 
 
72 CTC+CCC+CTG +3 bp P271a 1 
 
73 GG+CTA+T +3 bp Y261a 1 
 
74 GGT+GCT+CTA +3 bp A261a 2 
 
75 T+CT+GGC +2 bp frameshift n.a. 
 
76 GGT+CCT+GTA +3 bp P261a 2 
  77 GGTC+CA+TAG +2 bp frameshift n.a. 
 
  
Supplementary Table S16. Methods developed for the generation of libraries with random insertions, repeats and/or deletions. 
 
Method Principle Mutational scope 
(Type of mutations/Number per target 
sequence) 
Frameshift 
InDels (%) 
Reference 
RID Random Insertion/Deletion mutagenesis. 
(1) A circular single-stranded DNA (ssDNA) corresponding to the sense chain of the 
target gene is produced from the linear double-stranded target gene by linker 
ligation, restriction digestion, circularization by self-ligation and exonuclease 
digestion to remove the anti-sense chain. (2) Random cleavage (linearization) of the 
circular ssDNA at single positions by treatment with Ce(IV)–EDTA complex. (3) 
Ligation of 5’- and 3’- anchors at both ends of the ssDNA. These anchors are 
designed differently depending whether a deletion or an insertion is to be introduced. 
(4) PCR amplification of the DNAs linked to the two anchors at both ends. (5) 
Digestion by a type IIS restriction enzyme (e.g., BciVI) removes the anchor and 
leaves a deletion or an insertion in the target gene (depending on how the anchors’ 
sequences have been designed). (6) Reconstitution of the target gene by self-
ligation (re-circularization) and linearization by restriction digestion. The resulting 
products can then be cloned in a vector to finalize the variant library. 
One single InDel per variant; the procedure 
also generates random point substitutions 
presumably during the PCR step.[a] 
~10%  
 
 
 
20 
Segmental 
mutagenesis 
(1) The vector is first linearized either at the 5′ or 3′ end of the target gene. (2) 
Progressive BAL-31 exonuclease action and removal of the remaining vector DNA 
yields two batches of either 3′ or 5′ truncated gene fragments. (3) Combinatorial 
assembly of these two ends to generate variants of the target gene yields the 
segmental mutagenesis library which is then ligated into a vector and transformed 
into E.coli. 
One single deletion or one tandem repeat per 
variant (on a defined region of the target gene) 
~66%  
 
21 
RAISE RAndom Insertional-deletional Strand Exchange mutagenesis. 
(1) The target gene is fragmented using DNAseI. (2) The obtained fragments are 
extended randomly using Terminal deoxynucleotidyl transferase (TdT). (3) Assembly 
PCR with the TdT-extended fragment results in the shuffling of InDels and 
substitutions (generated by TdT or during the PCR steps) within the target gene. 
Combination of region-exchanged mutations 
and substitutions. [b] 
~66%  
22 
COBARDE Codon-based random deletion mutagenesis. 
(1) Chemical synthesis (based on the phosphoramidite method) generating a 
population of mutagenic oligonucleotides with multiple codon deletions in reference 
to the target gene. The mutagenic process consists of multiple successive cycles of 
3-nucleotide extension as follow: (i) transient blockage of a fraction of the 
synthesized oligos, (ii) extension of the unblocked oligos by 3 nucleotides, (iii) 
removal of the blocking groups. (2) The resulting oligonucleotide mixture 
(corresponding the deletion variants) is purified, duplexed using a DNA polymerase 
and ligated into a vector. 
One or multiple combined codon-based 
deletions per variant (usually on a defined 
region of the target gene). [c] 
<5%  
 
 
23 
TRINS Tandem repeat insertion (TRINS). 
(1) The target gene is fragmented using DNAseI. (2) An aliquot of the generated 
fragments is converted into single-stranded circular DNA using CircLigase. (3) 
Tandem repeats are generated by mixing linear fragments together with circularized 
fragments in an assembly PCR reaction involving rolling-circle polymerisation. (4) 
Assembly PCR products are then cloned to finalized the TRINS library. 
One or multiple tandem repeats per variants. 
Tandem repeat size variable (depending on 
the size of the initial DNAseI linear fragment). 
[d] 
~66%  
 
24 
Pentapeptide 
scanning 
(1) An engineered transposon is randomly inserted within the vector containing the 
target gene by in vivo or in vitro reaction (depending on the type of transposon 
One single insertion of defined size and 
sequence (5 nucleotide triplets) per variant. 
Not reported  
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used). The sub-library consisting of only of the target gene with a single transposon 
insertion can be isolated by DNA electrophoresis and size selection. (2) Restriction 
digestion (e.g., with NotI in the case of modified Mu transposon) leaves a 15 bp 
insertion after self-ligation of the target gene. 
25, 26 
TND Triplet nucleotide deletion 
1) An engineered transposon (dubbed MuDel) is randomly inserted within the vector 
containing the target gene using in vitro. The sub-library consisting of only of the 
target gene with a single transposon insertion can be isolated by DNA 
electrophoresis and size selection. (2) Digestion with type IIS restriction enzyme 
MlyI, results in a triplet deletion upon self-ligation of the target gene. 
One single nucleotide triplet deletion per 
variant. [e] 
Not reported  
 
1, 27 
CDM Codon Deletion Mutagenesis 
1) The target gene is cloned in a vector such as the resulting protein is N-terminally 
fused to an intein. (2) An engineered transposon (dubbed MuCDM) is then randomly 
inserted within the target gene using in vitro. MuCDM contains an intein sequence 
fused to an antibiotic resistance (e.g., TEM1), thus enabling selection only if 
transposon insertion is in the reading frame of the target gene. (3) An inverse PCR 
reaction with primers based on the transposon’s terminal sequences is performed to 
amplify the vector from the transposon’s insertion point. These primers carry a 
carefully positioned type IIS restrictions site (e.g., for BsgI) to remove a specific 
number of nucleotides from the resulting inverse PCR product. (3) Digestion by the 
type IIS restriction enzyme removes 1 to 5 nucleotide codons from the target gene 
depending on the positioning of the recognition sequence on the primers. (4) CDM 
libraries are generated upon self-ligation and transformation of the vector carrying 
the target gene variants in E. coli. 
Deletions of one to five consecutive codons. [f] 
 
<10%  
 
 
 
 
28 
Extensive gene 
truncation 
1) An engineered transposon (MuDel) is randomly inserted within the target gene by 
in vitro transposition. (2) 5′ and 3′ fragment sub-libraries of the target gene are 
amplified in two separate PCR reactions. In each reaction, one primer is 
complementary to the 5′ or 3′ constant regions of the target gene (adding BsaI at 
these ends), and the other to a sequence located in the transposon. (3) Digestion 
with BsaI creates unique overhangs in each sub-library complementary to unique 
overhangs in a DNA linker (free of MlyI sites) to favor directional ligation between 
these sub-libraries and the linker (4) The product of ligation was digested with MlyI 
removing the transposon sequence. (5) Intramolecular blunt-end ligation results in a 
circular product joining the 5′ and 3′ terminal fragments of the target gene. This 
circularized product is a library corresponding to the target genes with extensive 
truncation. (7) PCR on this circular library with primers complementary to the termini 
of the target gene results in a linear version of the extensive truncation library. (8) 
The final library of truncated variants of the desired size range is isolated by gel 
electrophoresis and cloned in a vector. 
Extensive DNA truncations of desired size 
range. [g] 
Not reported 29 
InDel assembly Assembly approach relying on successive cycles of DNA restriction and ligation to 
assemble a DNA library on beads. At each assembly cycle, DNA templates 
immobilized on beads are restricted with a type IIs endonuclease (e.g., SapI) and 
building blocks annealed and ligated. After ligation, the cycle can be restarted. 
Compositional variation is achieved primarily by combining controlled pools of 
building blocks of various length. 
One or multiple combined codon-based 
insertions and deletions per variant (usually on 
a defined region of the target gene). [h] 
Not reported  
 
30 
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[a] The RID mutagenesis was validated by randomly replacing three consecutive bases by recognition sequence for BglII (AGATCT) in the GFPuv gene: 17 variants (out of 19 randomly picked 
variants for sequencing; ~90%) displayed the desired mutations; 2 variants out of the pool of 19 variants (~10%) were frameshifted (deletion of 4 consecutive bases instead of 3); in addition, 6 
variants out of 19 (~30%) also displayed single point substitution. The RID mutagenesis has also been applied to randomly replace three consecutive bases by a mixture of 20 codons, effectively 
resulting in point substitution mutants. 
 
[b] RAISE was validated using TEM-1 beta-lactamase as target gene. After transformation of the library (~2,000 variants), 41 colonies were randomly picked and sequenced leading to the 
identification of region-exchanged mutations and point substitutions. Twenty-nine region-exchanged mutations were found in 19 variants. The number of the region-exchanged mutations per variant 
was 1 (12 variants), 2 (6 variants), or 5 (1 variants). Approximately two-thirds of the region-exchanged mutations were frameshifts. Seventy-nine point substitutions were identified over 34 variants, 
among which 15 had also region-exchanged mutations. Three variants out of the 41 that sequenced were parental sequences, presumably due to vector self-ligation. 
 
[c] COBARDE was validated using a sequence of 9 residues forming the omega loop in TEM-1 beta-lactamase: 4 parental sequences (presumably vector self-ligation) and 1 frame-shift (insertion of 
1 bp) were found out of 34 sequenced transformants. 
 
[d] TRINS was validated using three different templates: TEM-1 beta-lactamase, m.HaeIII methyltransferase and KE70 R6 (a laboratory-evolved variant of computationally designed Kemp 
eliminase). Out of 35 sequenced variants (from the three naïve libraries), 27 carried one insertion per gene, 4 had two and 4 had three. Two-third of the tandem repeats (23 of 35) resulted in 
frameshift. The sequenced variants also carried ~2 random point substitutions per variant presumably incorporated during PCR steps. 
 
[e] TND was validated using TEM-1 beta-lactamase (Jones, 2005) and eGFP (Baldwin et al., 2009; Arpino et al., 2014) as templates. In the case of TEM-1, the library generation process was 
combined with two consecutive selection steps: (i) selection for loss of ampicillin resistance upon transposition insertion within bla) and (ii) selection for retention of antibiotic resistance upon triplet 
nucleotide deletion. In the case of eGFP, the final library consisted of ~2,500 variants and 153 variants were chosen for sequencing based on the colony phenotype (88 fluorescent and 65 
nonfluorescent). This led to the identification of 87 unique triplet deletions (out of 153): 42 triplet deletions among the 88 fluorescent variants and 45 among the 65 nonfluorescent ones. No additional 
point substitutions or frameshifts were observed among the sequenced variants. 
 
[f] CMD was validated using super folder GFP (sfGFP) as template. Five libraries, corresponding to the deletion of 1 to 5 consecutive codons, were generated and around 20 variants from each 
library (amounting to a total of 104 sequences) were sequenced, showing that the majority of the variants (~92%) contained the desired deletions. Eight out of 104 sequences had either no 
mutations or unwanted mutations, most of them due to incomplete BsgI digestion.  
 
[g] The extensive gene truncation method was validated using an artificial RNA ligase enzyme (DNA size ~ 350 bp) as template and resulted in a library with truncations up to ~235 bp. Next 
generation sequencing analysis of the library revealed that it contained 9,006 unique deletions (~32% of the 27,730 possible unique deletions in this size range). The distribution of deletion lengths 
was found to range between 6 and 235 nucleotides in length. Deletions longer than 110 bp were observed at 50% or greater of the number of all possible deletions. The library was subjected to in 
vitro selection and functional variants with deletions of up to 18 amino acids of the parental enzyme. 
 
[h] InDel assembly was validated using part of TEM-1 beta-lactamase’s omega loop (5 residues, 164RWEPE168). The library was designed in order to explore the sequence neighbourhood of a 
previously reported variant (164RYYGE168) by using biased mixes of building blocks. The resulting library was analysed by next-generation sequencing before and after selection for ceftazidime 
resistance and demonstrated selective enrichment of the target sequence (164RYYGE168) as well as variants with extensions (e.g., 164RGYMKER168b).  
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Supplementary Table S17. Oligonucleotides used in this study. 
 
Experiment Oligonucleotide name and sequence 
Preparation of SubsNNN by PCR using pUC57-
Del2 as template  
Subs-F: 5'-[Phos]-ATGTCGACTCGACTAGTGCTTGGATTCTCA-3’  
Subs-B: 5'-[Phos]-NNNGGGATGACTCCATGGACTTCGC-3’  
(MlyI sites underlined) 
TransIns adapter to generate pUC57-TransIns 
from pUC57-TransDel 
TransIns-F: 5'-[Phos]- 
AATTCAGATCTGCGGCCGCGCACGAAAAACGCGAAAGCGTTTCACGAT-
AAATGCGAAAACGGA -3'  
TransIns-R: 5'-[Phos]- 
CTAGTCCGTTTTCGCATTTATCGTGAAACGCTTTCGCGTTTTTCGTGCG-
CGGCCGCAGATCTG-3'  
(NotI sites underlined) 
Del3 adapter to generate pUC57-Del3 from 
pUC57-Del2 
Del3-F: 5'-[Phos]-CATGGAGTCATCCCGGGA-3' 
Del3-R: 5'-[Phos]-AGCTTCCCGGGATGACTC-3' 
Ins adapter to generate pUC57-Ins from pUC57-
Del2 
Ins-F: 5'-[Phos]-AATTCTAGATCTGCGGCCGCATCCGTCTTCAGTCGCTGCTGA-3' 
Ins-R: 5'-[Phos]-CTAGTCAGCAGCGACTGAAGACGGATGCGGCCGCAGATCTAG-3' 
Ins1/2/3 adapter to generate libraries pUC57-
Ins1/2/3 from pUC57-Ins 
Ins1/2/3-F: 5'-[Phos]-CATGGCTGAAGGCCACTCGAGATCGAT (NNN)1/2/3 GCGCTGACTCA-3' 
Ins1/2/3-R: 5'-[Phos]-AGCTTGAGTCAGCGC (NNN)1/2/3 ATCGATCTCGAGTGGCCTTCAGC-3' 
Removal of MlyI recognition site in the origin of 
replication of pUC19 by saturation mutagenesis 
Ori-MlyI-F: 5'-ACCCGGTAAGACACGACTTATCGCCACTGGCA-3' 
Ori-MlyI-B: 5'-GTGTCTTACCGGGTTGGNNTCAAGACGATAGTTACCGGA-3' 
Removal of AcuI recognition site in the origin of 
replication of pUC19 by saturation mutagenesis 
Ori-AcuI-F: 5'-TATCTGCGCTCTGNNGAAGCCAGTTACCTT-3' 
Ori-AcuI-B: 5'-AGCGCAGATACCAAATACTGTTCTTCTAGTGTAGCCGTA-3' 
Amplification of the origin of replication of pUC19 
for assembly into the pID vectors 
Ori-AflII: 5'-GGACTTAAGGAGCAAAAGGCCAGCAAAAGG-3' 
Ori-SpeI: 5'-GCACACTAGTCTCATGACCAAAATCCCTTAACG-3' 
(1) Amplification of TetR from pASK-IBA5plus 
(TetR-F/TetR-B) 
(2) Amplification of AmpR from pID-T7 (mTEM1-
F/mTEM1-B) 
(3) Overlap PCR to form AmpR-TetR operon 
(mTEM1-F/TetR-B) 
TetR-F: 5'-TGATTAAGCATTGGTAGGAATTAATGATGTCTCGTT-3' 
TetR-B: 5'-TTAAACTAGTGAAGTTACCATCACGGA-3' 
mTEM1-F: 5'-CTGAAAGGACGTCAGGTGGCAC-3' 
mTEM1-B: 5'-TAATTCCTACCAATGCTTAATCAGTGAGGCA-3' 
Amplification of Tet promoter from pASK-IBA5plus Tet-prom-F: 5'-AGGCTTAAGACATGACCCGACACCATCGA-3' 
Tet-prom-B: 5'-GGCTCATATGTATATCTCCTTCTTAAAG-3' 
  SI-86  
SUPPLEMENTARY REFERENCES 
 
1. Jones DD. Triplet nucleotide removal at random positions in a target gene: the tolerance of 
TEM-1 beta-lactamase to an amino acid deletion. Nucleic Acids Res 33, e80 (2005). 
2. DePristo MA, Weinreich DM, Hartl DL. Missense meanderings in sequence space: a 
biophysical view of protein evolution. Nat Rev Genet 6, 678-687 (2005). 
3. Mayer S, Rudiger S, Ang HC, Joerger AC, Fersht AR. Correlation of levels of folded 
recombinant p53 in escherichia coli with thermodynamic stability in vitro. J Mol Biol 372, 268-
276 (2007). 
4. Wyganowski KT, Kaltenbach M, Tokuriki N. GroEL/ES buffering and compensatory mutations 
promote protein evolution by stabilizing folding intermediates. J Mol Biol 425, 3403-3414 
(2013). 
5. Lu Q. Seamless cloning and gene fusion. Trends Biotechnol 23, 199-207 (2005). 
6. Afriat-Jurnou L, Jackson CJ, Tawfik DS. Reconstructing a missing link in the evolution of a 
recently diverged phosphotriesterase by active-site loop remodeling. Biochemistry 51, 6047-
6055 (2012). 
7. Hoque MA, et al. Stepwise Loop Insertion Strategy for Active Site Remodeling to Generate 
Novel Enzyme Functions. ACS Chem Biol 12, 1188-1193 (2017). 
8. Kaltenbach M, Emond S, Hollfelder F, Tokuriki N. Functional Trade-Offs in Promiscuous 
Enzymes Cannot Be Explained by Intrinsic Mutational Robustness of the Native Activity. 
PLoS Genet 12, e1006305 (2016). 
9. Ikeda RA, Ligman CM, Warshamana S. T7 promoter contacts essential for promoter activity 
in vivo. Nucleic Acids Res 20, 2517-2524 (1992). 
10. Zhang J, Kobert K, Flouri T, Stamatakis A. PEAR: a fast and accurate Illumina Paired-End 
reAd mergeR. Bioinformatics 30, 614-620 (2014). 
11. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 9, 357-
359 (2012). 
12. Li H, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 
(2009). 
13. Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software 
Suite. Trends Genet 16, 276-277 (2000). 
  SI-87  
14. Tokuriki N, Jackson CJ, Afriat-Jurnou L, Wyganowski KT, Tang R, Tawfik DS. Diminishing 
returns and tradeoffs constrain the laboratory optimization of an enzyme. Nat Commun 3, 
1257 (2012). 
15. Campbell E, et al. The role of protein dynamics in the evolution of new enzyme function. Nat 
Chem Biol 12, 944-950 (2016). 
16. Kaltenbach M, Jackson CJ, Campbell EC, Hollfelder F, Tokuriki N. Reverse evolution leads to 
genotypic incompatibility despite functional and active site convergence. Elife 4,  (2015). 
17. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol 
Biol 372, 774-797 (2007). 
18. Miller S, Janin J, Lesk AM, Chothia C. Interior and surface of monomeric proteins. J Mol Biol 
196, 641-656 (1987). 
19. Tokuriki N, Stricher F, Schymkowitz J, Serrano L, Tawfik DS. The stability effects of protein 
mutations appear to be universally distributed. J Mol Biol 369, 1318-1332 (2007). 
20. Murakami H, Hohsaka T, Sisido M. Random insertion and deletion of arbitrary number of 
bases for codon-based random mutation of DNAs. Nat Biotechnol 20, 76-81 (2002). 
21. Pikkemaat MG, Janssen DB. Generating segmental mutations in haloalkane dehalogenase: a 
novel part in the directed evolution toolbox. Nucleic Acids Res 30, E35-35 (2002). 
22. Fujii R, Kitaoka M, Hayashi K. Random insertional-deletional strand exchange mutagenesis 
(RAISE): a simple method for generating random insertion and deletion mutations. Methods 
Mol Biol 1179, 151-158 (2014). 
23. Osuna J, Yanez J, Soberon X, Gaytan P. Protein evolution by codon-based random 
deletions. Nucleic Acids Res 32, e136 (2004). 
24. Kipnis Y, Dellus-Gur E, Tawfik DS. TRINS: a method for gene modification by randomized 
tandem repeat insertions. Protein Eng Des Sel 25, 437-444 (2012). 
25. Hallet B, Sherratt DJ, Hayes F. Pentapeptide scanning mutagenesis: random insertion of a 
variable five amino acid cassette in a target protein. Nucleic Acids Res 25, 1866-1867 (1997). 
26. Hayes F, Hallet B. Pentapeptide scanning mutagenesis: encouraging old proteins to execute 
unusual tricks. Trends Microbiol 8, 571-577 (2000). 
27. Arpino JA, Reddington SC, Halliwell LM, Rizkallah PJ, Jones DD. Random single amino acid 
deletion sampling unveils structural tolerance and the benefits of helical registry shift on GFP 
folding and structure. Structure 22, 889-898 (2014). 
  SI-88  
28. Liu SS, Wei X, Ji Q, Xin X, Jiang B, Liu J. A facile and efficient transposon mutagenesis 
method for generation of multi-codon deletions in protein sequences. J Biotechnol 227, 27-34 
(2016). 
29. Morelli A, Cabezas Y, Mills LJ, Seelig B. Extensive libraries of gene truncation variants 
generated by in vitro transposition. Nucleic Acids Res 45, e78 (2017). 
30. Tizei PAG, Harris E, Renders M, Pinheiro VB. InDel assembly: A novel framework for 
engineering protein loops through length and compositional variation (2017), bioarxiv, 
doi.org/10.1101/127829.  
 
 
 
